https://curecurrent.com/trials/a-multicenter-prospective-cohort-study-of-adjuvant-therapy-for-brca1-2-mutated-hormone-receptor-positive-her2-negative-e-30001https://curecurrent.com/trials/treatment-of-vulvo-vaginal-atrophy-vva-using-vaginal-dilator-in-addition-to-usual-treatment-30002https://curecurrent.com/trials/effect-of-neo-adjuvant-therapy-on-lipids-in-young-breast-cancer-patients-30003https://curecurrent.com/trials/in-depth-characterization-of-circulating-and-infiltrating-immune-subsets-and-tumor-cells-in-cancer-patients-30004https://curecurrent.com/trials/intensive-adjuvant-therapy-for-tnbc-with-brca-gene-mutation-30005https://curecurrent.com/trials/a-study-comparing-the-differences-between-young-and-non-young-breast-cancer-30006https://curecurrent.com/trials/margetuximab-expanded-access-program-30007https://curecurrent.com/trials/evaluation-of-lasofoxifene-combined-with-abemaciclib-in-advanced-or-metastatic-er-her2-breast-cancer-with-an-esr1-mutati-30008https://curecurrent.com/trials/performance-assessment-of-the-fluorescence-technique-alone-in-the-search-for-the-sentinel-node-in-breast-surgery-30009https://curecurrent.com/trials/education-intervention-in-patients-with-rash-due-to-epidermal-growth-factor-receptor-egfr-treatment-30010https://curecurrent.com/trials/a-clinical-study-to-explore-the-efficacy-and-safety-of-hyperbaric-oxygen-in-the-neoadjuvant-treatment-of-hormone-recepto-30011https://curecurrent.com/trials/a-study-of-ac682-for-the-treatment-of-locally-advanced-or-metastatic-er-breast-cancer-30012https://curecurrent.com/trials/letrozole-or-tamoxifen-citrate-in-treating-older-postmenopausal-women-undergoing-surgery-for-breast-cancer-30013https://curecurrent.com/trials/sexual-quality-of-life-in-women-during-the-first-year-of-adjuvant-hormonal-treatment-for-breast-cancer-30014https://curecurrent.com/trials/a-pilot-study-of-geriatric-specific-interventions-for-quality-of-life-in-elderly-patients-with-cancer-30015https://curecurrent.com/trials/cold-dissection-versus-electrocautery-dissection-in-endoscopic-nipple-sparing-mastectomy-and-immediate-implant-based-rec-30016https://curecurrent.com/trials/study-assessing-the-efficacy-and-safety-of-alpelisib-plus-fulvestrant-in-men-and-postmenopausal-women-with-advanced-brea-30017https://curecurrent.com/trials/a-phase-ii-single-arm-clinical-study-to-explore-the-efficacy-and-safety-of-hyperbaric-oxygen-in-the-neoadjuvant-treatmen-30018https://curecurrent.com/trials/using-imaging-data-and-genomic-data-to-predict-metastasis-of-breast-cancer-after-treatment-30019https://curecurrent.com/trials/use-of-microporous-polysaccharide-hemispheres-in-breast-cancer-patients-undergoing-mastectomy-30020https://curecurrent.com/trials/development-of-clinical-and-biological-database-30021https://curecurrent.com/trials/efficacy-of-interleukin-2-in-triple-negative-breast-cancer-30022https://curecurrent.com/trials/the-effect-of-coconut-oil-on-alopecia-30023https://curecurrent.com/trials/hyperbaric-oxygen-in-the-prevention-of-radiation-pneumonitis-30024https://curecurrent.com/trials/pelvic-health-rehabilitation-after-breast-and-gynecologic-cancer-30025https://curecurrent.com/trials/professional-life-after-breast-cancer-feasibility-of-a-coaching-program-for-an-adapted-return-to-work-30026https://curecurrent.com/trials/a-clinical-study-of-albumin-bound-paclitaxel-granulocyte-based-therapy-for-recurrent-metastatic-breast-cancer-30027https://curecurrent.com/trials/prevention-of-cardiac-dysfunction-during-breast-cancer-therapy-30028https://curecurrent.com/trials/validation-of-tad-in-her-2-with-more-than-2-lymph-nodes-30029https://curecurrent.com/trials/improving-theempowerment-in-patients-with-severe-breast-fibrosis-radio-induced-treated-by-pravastatin-benefit-of-e-pros-30030https://curecurrent.com/trials/use-of-topical-olive-oil-cream-for-prophylaxis-against-acute-radiodermatitis-in-breast-cancer-patients-30031https://curecurrent.com/trials/hybrid-molecular-imaging-of-er-in-breast-cancer-patients-with-dcis-30032https://curecurrent.com/trials/endoscopy-robotic-assisted-nipple-skin-sparing-mastectomy-30033https://curecurrent.com/trials/targeted-resection-of-axillary-metastatic-lymph-nodes-after-breast-cancer-neoadjuvant-chemotherapy-30034https://curecurrent.com/trials/clinical-database-of-safe-personalized-adjuvant-breast-radiotherapy-based-on-individual-radiosensitivity-30035https://curecurrent.com/trials/phase-i-ii-clinical-study-to-evaluate-vb15010-tablets-in-patients-with-advanced-solid-tumors-30036https://curecurrent.com/trials/molecular-analysis-of-breast-cancer-30037https://curecurrent.com/trials/thyroid-dysfunction-induced-by-radiotherapy-treatment-in-patients-with-breast-cancer-30038https://curecurrent.com/trials/demonstrate-efficacy-and-safety-of-metastatic-breast-cancer-30039https://curecurrent.com/trials/hyperbaric-oxygen-therapy-for-peripheral-neuropathy-due-to-paclitaxel-analogs-30040https://curecurrent.com/trials/radiotherapy-exposed-lung-injury-effect-on-functioning-cohort-30041https://curecurrent.com/trials/phase-i-trial-of-afatinib-and-trastuzumab-in-her2-overexpressing-cancer-30042https://curecurrent.com/trials/adjuvant-trastuzumab-pertuzumab-plus-docetaxel-in-the-treatment-of-early-her2-positive-breast-cancer-30043https://curecurrent.com/trials/neoadjuvant-toripalimab-and-radiotherapy-treatment-in-n-hr-breast-cancer-30044https://curecurrent.com/trials/a-safety-study-of-sea-tgt-sgn-tgt-in-advanced-cancer-30045https://curecurrent.com/trials/effects-of-music-and-affirmation-recital-in-women-with-breast-cancer-30046https://curecurrent.com/trials/icbt-and-iemdr-ft-for-mental-health-in-breast-cancer-patients-30047https://curecurrent.com/trials/phase-i-open-label-trial-to-assess-safety-of-bibw-2992-afatinib-in-combination-with-herceptin-in-patients-with-her2-posi-30048https://curecurrent.com/trials/family-history-in-a-singapore-oncology-population-30049https://curecurrent.com/trials/the-vitality-mammography-messaging-study-30050https://curecurrent.com/trials/quality-of-life-in-patients-with-standard-external-compared-to-custom-made-breast-prosthesis-30051https://curecurrent.com/trials/trial-comparing-the-effects-of-linear-versus-nonlinear-aerobic-training-in-women-with-operable-breast-cancer-30052https://curecurrent.com/trials/effect-of-subanesthetic-dose-of-esketamine-on-sleep-quality-30053https://curecurrent.com/trials/an-integrated-algorithm-for-surgical-intervention-in-chronic-lymphedema-after-breast-cancer-treatment-the-basel-lymphede-30054https://curecurrent.com/trials/a-study-of-diffusing-alpha-radiation-therapy-for-patients-with-breast-carcinoma-in-frail-or-elderly-patients-30055https://curecurrent.com/trials/implementation-of-solid-digital-pcr-to-support-gold-standard-methods-for-evaluation-of-her2-amplification-status-focus-o-30056https://curecurrent.com/trials/multicenter-study-to-evaluate-a-systematized-communication-model-for-breast-cancer-patients-30057https://curecurrent.com/trials/romidepsin-in-treating-patients-with-lymphoma-chronic-lymphocytic-leukemia-or-solid-tumors-with-liver-dysfunction-30058https://curecurrent.com/trials/effects-of-tdcs-intervention-on-neoadjuvant-chemotherapy-in-breast-cancer-patients-with-mild-to-moderate-depression-30059https://curecurrent.com/trials/a-study-of-sgn-stnv-in-advanced-solid-tumors-30060https://curecurrent.com/trials/exploring-cultural-acceptability-of-community-breast-cancer-risk-assessment-among-hispanic-women-in-maricopa-county-30061https://curecurrent.com/trials/randomized-study-to-evaluate-an-intervention-based-on-mindfulness-to-reduce-anxiety-in-breast-cancer-survivors-30062https://curecurrent.com/trials/an-episodic-future-thinking-intervention-to-promote-weight-loss-in-breast-cancer-survivors-30063https://curecurrent.com/trials/somesthesia-in-cancer-patients-variability-and-influence-on-eating-experience-30064https://curecurrent.com/trials/delayed-immediate-versus-delayed-breast-reconstruction-in-breast-cancer-patients-with-mastectomy-and-radiation-therapy-30065https://curecurrent.com/trials/karolinska-interventional-study-of-mammograhic-density-karisma-1-30066https://curecurrent.com/trials/survivor-stories-impact-on-cancer-patients-quality-of-life-and-follow-up-30067https://curecurrent.com/trials/cardiac-aggressive-risk-mitigation-in-thoracic-radiotherapy-carma-trial-30068https://curecurrent.com/trials/effect-of-bra-use-during-radiotherapy-for-breast-cancer-radiotherapy-30069https://curecurrent.com/trials/wi231696-bosutinib-palbocicilib-and-fulvestrant-for-hr-her2-advanced-breast-cancer-refractory-to-a-cdk4-6-inhibitor-30070https://curecurrent.com/trials/ql1706-plus-chemotherapy-bevacizumab-in-1l-treatment-of-r-mtnbc-30071https://curecurrent.com/trials/study-of-shr-a1811-combined-with-pyrotinib-and-bevacizumab-in-advanced-breast-cancer-with-brain-metastasis-30072https://curecurrent.com/trials/intraoperative-radiotherapy-after-local-recurrence-in-breast-cancer-30073https://curecurrent.com/trials/comparison-of-esp-and-spsip-blocks-in-breast-surgery-30074https://curecurrent.com/trials/evaluating-scaleup-of-an-adapted-breast-cancer-early-diagnosis-program-in-rwanda-30075https://curecurrent.com/trials/this-study-aims-to-explore-the-efficacy-of-hyperbaric-oxygen-in-the-treatment-of-flap-ischaemic-necrosis-after-breast-ca-30076https://curecurrent.com/trials/the-effect-of-oral-administration-of-hesperidin-and-diosmin-in-reducing-paclitaxel-induced-peripheral-neuropathy-in-brea-30077https://curecurrent.com/trials/imaging-quality-and-potential-clinical-relevance-of-phase-contrast-mammography-in-vivo-a-single-center-prospective-study-30078https://curecurrent.com/trials/marital-satisfaction-and-sexual-health-of-female-cancer-patients-in-singapore-30079https://curecurrent.com/trials/reducing-hot-flashes-in-women-using-endocrine-therapy-30080https://curecurrent.com/trials/study-of-the-efficacy-safety-and-pharmacokinetics-of-pamiparib-bgb-290-in-participants-with-advanced-solid-tumors-30081https://curecurrent.com/trials/balneotherapy-for-breast-cancer-patients-undergoing-endocrine-therapy-30082https://curecurrent.com/trials/pbi-for-breast-in-situ-carcinoma-of-intermediate-low-risk-as-local-adjuvant-treatment-30083https://curecurrent.com/trials/a-study-of-liposomal-doxorubicin-docetaxel-trastuzumab-metformin-in-operable-and-locally-advanced-her2-positive-breast-c-30084https://curecurrent.com/trials/transcripts-with-retained-h-aca-box-snorna-sequences-as-biomarkers-for-estrogen-dependence-in-lum-b-breast-carcinomas-30085https://curecurrent.com/trials/predicting-clinical-outcomes-during-first-line-cdk4-6-inhibitors-plus-endocrine-therapy-in-patients-with-advanced-hormon-30086https://curecurrent.com/trials/avidination-for-radionuclidetherapy-in-nonpalpable-breast-cancer-30087https://curecurrent.com/trials/safety-and-efficacy-study-of-the-xoft-axxent-ebx-iort-system-30088https://curecurrent.com/trials/controlled-ovarian-stimulation-in-newly-diagnosed-breast-cancer-patients-famhope-30089https://curecurrent.com/trials/surgical-and-patient-reported-outcomes-of-robotic-nipple-sparing-mastectomy-30090https://curecurrent.com/trials/kadcyla-and-neratinib-for-interception-of-her2-breast-cancer-with-molecular-residual-disease-30091https://curecurrent.com/trials/delayed-selective-sentinel-node-biopsy-for-patients-undergoing-mastectomy-for-dcis-30092https://curecurrent.com/trials/shave-margins-vs-standard-partial-mastectomy-in-breast-cancer-patients-30093https://curecurrent.com/trials/fertility-preservation-in-breast-cancer-patients-30094https://curecurrent.com/trials/genomic-investigation-of-unusual-responders-30095https://curecurrent.com/trials/improving-evidence-based-care-for-cancer-patients-30096https://curecurrent.com/trials/evaluating-efficacy-and-tolerability-of-anticancer-drug-therapies-for-the-treatment-of-gynecologic-and-breast-cancers-30097https://curecurrent.com/trials/induction-therapy-of-ptx-bv-followed-by-atezolizumab-nab-ptx-for-pd-l1-tnbc-30098https://curecurrent.com/trials/a-study-of-btx-a51-in-people-with-advanced-solid-tumor-and-breast-cancer-30099https://curecurrent.com/trials/the-impact-of-ai-supported-education-in-mastectomy-patient-30100https://curecurrent.com/trials/behavioural-science-messages-in-breast-cancer-screening-30101https://curecurrent.com/trials/preoperative-magnetic-resonance-imaging-to-obtain-adequate-resection-margins-in-breast-conserving-surgery-primar-trial-30102https://curecurrent.com/trials/immunotherapy-in-high-risk-ductal-carcinoma-in-situ-dcis-30103https://curecurrent.com/trials/a-window-trial-on-curcumin-for-invasive-breast-cancer-primary-tumors-30104https://curecurrent.com/trials/localization-of-breast-cancer-with-the-sirius-pintuition-magnetic-seed-30105https://curecurrent.com/trials/who-and-why-do-patients-report-lymphedema-after-breast-cancer-treatment-without-an-objective-measurable-swelling-30106https://curecurrent.com/trials/a-dose-finding-study-of-zw49-in-patients-with-her2-positive-cancers-30107https://curecurrent.com/trials/real-world-patient-reported-outcome-of-sacituzumab-govitecan-in-chinese-metastatic-triple-negative-breast-cancer-30108https://curecurrent.com/trials/trilaciclib-in-patients-receiving-sacituzumab-govitecan-hziy-for-triple-negative-breast-cancer-30109https://curecurrent.com/trials/dendritic-cell-based-treatment-plus-immunotherapy-for-the-treatment-of-metastatic-or-unresectable-triple-negative-breast-30110https://curecurrent.com/trials/phii-icb-with-without-erbitux-in-mbc-pts-30111https://curecurrent.com/trials/phase-ii-study-of-pembrolizumab-and-nab-paclitaxel-in-her-2-negative-metastatic-breast-cancer-30112https://curecurrent.com/trials/the-effect-of-the-mobile-application-based-support-program-on-the-outcomes-of-breast-cancer-patients-in-the-pandemic-30113https://curecurrent.com/trials/the-effects-of-dance-for-breast-cancer-patients-undergoing-surgical-treatment-30114https://curecurrent.com/trials/monaco-serial-biological-function-k-value-index-constraint-for-cardiac-dose-30115https://curecurrent.com/trials/non-inferiority-study-on-mrna-lncrna-model-in-low-risk-triple-negative-breast-cancer-patients-30116https://curecurrent.com/trials/heterogeneity-of-68ga-fapi-uptake-as-imaging-biomarker-in-t-dxd-treatment-for-brain-metastasis-of-her2-positive-breast-c-30117https://curecurrent.com/trials/node-negative-invasive-breast-cancer-single-fraction-ioert-30118https://curecurrent.com/trials/the-effect-of-body-mass-index-and-total-cholesterol-levels-on-histopathological-grading-in-breast-cancer-patients-30119https://curecurrent.com/trials/anastrozole-and-letrozole-after-surgery-for-the-treatment-of-stage-i-iii-breast-cancer-30120https://curecurrent.com/trials/the-promise-study-duavee-in-women-with-dcis-30121https://curecurrent.com/trials/testosterone-in-treating-postmenopausal-patients-with-arthralgia-caused-by-adjuvant-aromatase-inhibitor-treatment-30122https://curecurrent.com/trials/exploring-the-tumor-micro-environment-with-68ga-fapi-46-pet-ct-in-breast-cancer-30123https://curecurrent.com/trials/brain-metastasis-in-triple-negateive-breast-cancer-ivonescimab-and-trop2-adc-30124https://curecurrent.com/trials/pre-existing-factors-early-detection-and-early-treatment-of-breast-cancer-related-lymphedema-30125https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-vepdegestrant-arv-471-pf-07850327-in-people-with-er-her2-advanced-breas-30126https://curecurrent.com/trials/trastuzumab-deruxtecan-with-nivolumab-in-advanced-breast-and-urothelial-cancer-30127https://curecurrent.com/trials/a-study-of-pembrolizumab-in-combination-with-trastuzumab-dm1-30128https://curecurrent.com/trials/the-opbc-07-micronac-study-30129https://curecurrent.com/trials/nostra-feasibility-study-a-study-looking-at-ultrasound-guided-biopsies-for-breast-cancer-30130https://curecurrent.com/trials/patient-outcomes-from-second-film-readers-and-test-threshold-relaxation-in-breast-screening-30131https://curecurrent.com/trials/a-study-to-investigate-the-biological-effects-of-azd9833-in-women-with-er-positive-her2-negative-primary-breast-cancer-30132https://curecurrent.com/trials/mhealth-for-breast-cancer-survivors-with-insomnia-30133https://curecurrent.com/trials/phase-1-clinical-trial-to-evaluate-the-safety-and-anti-tumor-activity-of-ab-201-30134https://curecurrent.com/trials/health-care-coach-support-in-reducing-acute-care-use-and-cost-in-patients-with-cancer-30135https://curecurrent.com/trials/diagnostic-performance-of-positron-emission-mammography-in-breast-cancer-30136https://curecurrent.com/trials/evaluate-safety-efficacy-and-pharmacokinetics-30137https://curecurrent.com/trials/the-impact-of-social-media-delivered-chemotherapy-side-effects-education-for-breast-cancer-patients-receiving-chemothera-30138https://curecurrent.com/trials/zoladex-10-8-bc-rws-30139https://curecurrent.com/trials/clinical-study-of-camrelizumab-combined-with-tcb-versus-tcb-in-neoadjuvant-treatment-of-triple-negative-breast-cancer-30140https://curecurrent.com/trials/investigation-of-anti-tumour-effect-and-tolerability-of-the-parp-inhibitor-2x-121-in-patients-with-metastatic-breast-can-30141https://curecurrent.com/trials/preoperative-evaluation-of-3d-reconstruction-tool-for-nipple-sparing-mastectomy-30142https://curecurrent.com/trials/acute-exercise-intervention-in-breast-cancer-survivors-30143https://curecurrent.com/trials/clinical-validation-of-the-role-of-microrna-binding-site-mutations-in-cancer-risk-prevention-and-treatment-30144https://curecurrent.com/trials/talazoparib-in-combination-with-belinostat-for-metastatic-breast-cancer-metastatic-castration-resistant-prostate-cancer-30145https://curecurrent.com/trials/the-effectiveness-of-lymphatic-bypass-supermicrosurgery-30146https://curecurrent.com/trials/onco-vascular-exer-study-30147https://curecurrent.com/trials/male-mamm-organoids-30148https://curecurrent.com/trials/e-health-portal-for-individualized-treatment-monitoring-and-patient-engagement-in-oncology-research-30149https://curecurrent.com/trials/intent-pilot-study-enhancing-adherence-intentions-to-endocrine-therapy-30150https://curecurrent.com/trials/proteomic-analysis-of-patients-undergoing-bariatric-surgery-30151https://curecurrent.com/trials/night-shift-work-and-breast-cancer-30152https://curecurrent.com/trials/efficacy-of-home-based-treatment-for-breast-cancer-related-lymphedema-30153https://curecurrent.com/trials/acupuncture-on-chemotherapy-induced-peripheral-neuropathy-30154https://curecurrent.com/trials/genomic-markers-for-measuring-breast-cancer-response-to-neoadjuvant-chemotherapy-30155https://curecurrent.com/trials/mri-screening-versus-symptom-directed-surveillance-for-brain-metastases-among-patients-with-triple-negative-or-her2-mbc-30156https://curecurrent.com/trials/integrated-patient-avatars-for-guiding-systemic-therapy-treatments-in-metastatic-breast-cancer-patients-30157https://curecurrent.com/trials/nodal-burden-and-nodal-recurrence-in-patients-with-isolated-tumor-cells-after-neoadjuvant-chemotherapy-treated-with-axil-30158https://curecurrent.com/trials/home-based-exercise-program-during-neoadjuvant-treatment-to-improve-fatigue-and-quality-of-life-in-early-her2-positive-a-30159https://curecurrent.com/trials/effectiveness-of-cdt-for-the-treatment-of-lymphedema-in-breast-cancer-patients-who-received-lva-surgery-30160https://curecurrent.com/trials/effects-of-radiotherapy-in-borderline-and-malignant-phyllodes-tumors-after-r0-resection-30161https://curecurrent.com/trials/com701-an-inhibitor-of-pvrig-in-subjects-with-advanced-solid-tumors-30162https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-the-efficacy-and-adverse-effects-of-neoadjuvant-therapy-in-patients-with-breast-c-30163https://curecurrent.com/trials/expanded-access-for-the-treatment-of-cancers-with-rearranged-during-transfection-ret-activation-30164https://curecurrent.com/trials/fluciclovine-and-psma-pet-ct-for-the-classification-and-improved-staging-of-invasive-lobular-breast-cancer-30165https://curecurrent.com/trials/regional-anesthesia-techniques-in-breast-surgery-30166https://curecurrent.com/trials/photo-medicine-guided-dual-approach-for-reoperation-of-sentinel-lymph-nodes-in-locally-recurrent-breast-cancer-patients-30167https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-chemotherapy-side-effects-after-adjuvant-chemotherapy-for-breast-cancer-30168https://curecurrent.com/trials/evaluation-of-mammographic-breast-density-in-participants-with-hormone-receptor-negative-breast-cancer-enrolled-on-study-30169https://curecurrent.com/trials/breast-screening-atypia-and-subsequent-development-of-cancer-in-england-30170https://curecurrent.com/trials/a-study-to-assess-overall-response-rate-by-inducing-an-inflammatory-phenotype-in-metastatic-breast-cancer-with-the-oncol-30171https://curecurrent.com/trials/southeast-asian-women-s-health-project-30172https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-or-without-talniflumate-for-the-treatment-of-breast-cancer-30173https://curecurrent.com/trials/dermatitis-during-adjuvant-irradiation-for-breast-cancer-30174https://curecurrent.com/trials/trial-assessing-light-intensity-exercise-on-the-health-of-older-breast-cancer-survivors-30175https://curecurrent.com/trials/safir02-breast-efficacy-of-genome-analysis-as-a-therapeutic-decision-tool-for-patients-with-metastatic-breast-cancer-30176https://curecurrent.com/trials/sleep-disorders-prior-to-and-during-a-course-of-radiotherapy-for-breast-cancer-30177https://curecurrent.com/trials/chronic-impacts-of-endocrine-therapy-on-cardiovascular-and-brain-health-outcomes-in-breast-cancer-30178https://curecurrent.com/trials/cab-ror2-adc-safety-and-efficacy-study-in-patients-with-tnbc-or-head-neck-cancer-ph1-and-nsclc-or-melanoma-ph2-30179https://curecurrent.com/trials/metronomic-oral-vinorelbine-plus-anti-pd-l1-anti-ctla4-immunotherapy-in-patients-with-advanced-solid-tumours-30180https://curecurrent.com/trials/feasibility-study-of-intraoperative-detection-of-residual-cancer-in-breast-cancer-patients-30181https://curecurrent.com/trials/electroacupuncture-treatment-of-peripheral-neuropathy-after-taxane-chemotherapy-for-breast-cancer-30182https://curecurrent.com/trials/registry-of-adjuvant-hormone-blockade-breast-cancer-patients-evaluated-for-bone-mineral-metabolism-30183https://curecurrent.com/trials/feasibility-study-of-a-neuromuscular-fatigue-test-and-associated-hemodynamic-responses-application-in-healthy-volunteers-30184https://curecurrent.com/trials/ultrasound-guided-thoracic-interfascial-plane-nerve-block-versus-erector-spinae-plane-block-for-pain-control-after-modif-30185https://curecurrent.com/trials/predicting-outcomes-of-breast-conserving-surgery-in-breast-cancer-patients-using-the-modified-5-item-frailty-index-30186https://curecurrent.com/trials/the-use-of-deep-inspiration-breath-hold-and-prone-irradiation-to-decrease-cardiac-radiation-exposure-30187https://curecurrent.com/trials/quilt-3-013-study-of-ad5-e1-e2b-her2-neu-vaccine-etbx-021-in-subjects-with-unresectable-locally-advanced-or-metastatic-h-30188https://curecurrent.com/trials/feasibility-study-of-a-molecular-karyotype-using-a-very-high-throughput-sequencing-approach-the-massive-parallel-sequenc-30189https://curecurrent.com/trials/the-dosing-regimen-of-pyrotinib-in-her2-positive-advanced-first-line-breast-cancer-a-phase-i-clinical-study-30190https://curecurrent.com/trials/a-clinical-study-of-9mw2821-and-pd-1-inhibitor-in-locally-advanced-or-metastatic-triple-negative-breast-cancer-30191https://curecurrent.com/trials/glucose-monitoring-during-chemotherapy-30192https://curecurrent.com/trials/a-study-of-the-gut-microbiome-in-hormone-receptor-positive-her2-negative-breast-cancer-treated-with-cdk4-6-inhibitors-30193https://curecurrent.com/trials/intervening-on-women-s-health-for-rural-young-breast-cancer-survivors-30194https://curecurrent.com/trials/sub-regional-tumor-segmentation-based-on-ceus-perfusion-characteristics-enhancing-breast-tumor-diagnosis-30195https://curecurrent.com/trials/rct-comparing-espb-solutions-in-breast-surgery-30196https://curecurrent.com/trials/a-randomized-controlled-study-on-the-efficacy-and-safety-of-neoadjuvant-radiotherapy-combined-with-systemic-therapy-for-30197https://curecurrent.com/trials/sulfasalazine-in-decreasing-opioids-requirements-in-breast-cancer-patients-30198https://curecurrent.com/trials/the-effect-of-a-self-management-lymphedema-education-program-on-lymphedema-symptoms-compliance-daily-living-activities-a-30199https://curecurrent.com/trials/effect-of-genetic-polymorphism-on-capecitabine-induced-toxicity-in-egyptian-cancer-patients-30200https://curecurrent.com/trials/contrast-enhanced-spectral-mammography-vs-mri-for-breast-cancer-screening-30201https://curecurrent.com/trials/explore-association-models-between-environmental-hormones-andbreast-cancer-30202https://curecurrent.com/trials/study-evaluating-the-antitumor-activity-and-safety-of-niraparib-as-neoadjuvant-treatment-in-participants-with-breast-can-30203https://curecurrent.com/trials/reset-brain-rehabilitation-of-sleep-and-cognitive-impairment-in-breast-cancer-survivors-using-an-app-based-intervention-30204https://curecurrent.com/trials/minocycline-hydrochloride-in-reducing-chemotherapy-induced-depression-and-anxiety-in-patients-with-stage-i-iii-breast-ca-30205https://curecurrent.com/trials/a-low-age-advanced-glycation-end-product-dietary-intervention-for-breast-cancer-survivors-30206https://curecurrent.com/trials/a-pharmacokinetic-and-randomized-trial-of-neoadjuvant-treatment-with-anastrozole-plus-azd0530-in-postmenopausal-patients-30207https://curecurrent.com/trials/a-composite-assay-for-her2-positive-early-stage-breast-cancer-management-30208https://curecurrent.com/trials/study-of-nivolumab-versus-placebo-in-combination-with-neoadjuvant-chemotherapy-and-adjuvant-endocrine-therapy-in-partici-30209https://curecurrent.com/trials/exercises-using-virtual-reality-on-cancer-patients-30210https://curecurrent.com/trials/cuff-shape-and-postoperative-sore-throat-in-breast-cancer-patients-30211https://curecurrent.com/trials/organoids-based-drug-sensitivity-in-neoadjuvant-chemotherapy-of-breast-cancer-30212https://curecurrent.com/trials/drug-sensitivity-of-hydrothorax-and-ascite-organoids-from-breast-cancer-30213https://curecurrent.com/trials/ctdna-based-mrd-testing-for-nac-monitoring-in-tnbc-30214https://curecurrent.com/trials/erector-spinae-plane-block-vs-pecs-i-ii-blocks-after-breast-conserving-surgery-30215https://curecurrent.com/trials/age-levels-in-er-metastatic-breast-cancer-patients-receiving-endocrine-therapy-30216https://curecurrent.com/trials/the-added-value-of-contrast-enhanced-mammography-to-standard-mammography-in-assessing-the-extent-of-dcis-30217https://curecurrent.com/trials/studying-the-role-of-key-epigenetic-mediators-in-breast-cancer-patients-30218https://curecurrent.com/trials/gene-expression-meditative-movement-and-emotional-distress-gme-30219https://curecurrent.com/trials/comparative-evaluation-of-pectoral-nerve-block-type-ii-versus-rhomboid-intercostal-and-subserratus-plane-block-in-breast-30220https://curecurrent.com/trials/palbociclib-endocrine-therapy-followed-by-talazo-vs-talazoz-atezo-study-30221https://curecurrent.com/trials/a-phase-i-ii-trial-to-evaluate-oral-hp568-tablets-in-patients-with-er-her2-advanced-breast-cancer-30222https://curecurrent.com/trials/couples-qol-in-metastatic-breast-cancer-30223https://curecurrent.com/trials/hypofractionated-postoperative-regional-nodal-irradiation-for-patients-with-intermediate-risk-breast-cancer-30224https://curecurrent.com/trials/a-clinical-trial-to-investigate-the-clinical-drug-drug-interaction-of-divarasib-with-probe-substrates-of-p-glycoprotein-30225https://curecurrent.com/trials/effects-of-rhomboid-intercostal-block-on-postoperative-pain-management-and-chronic-pain-incidence-in-mastectomies-30226https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-for-maintenance-therapy-after-first-line-th-p-therapy-for-her2-abc-30227https://curecurrent.com/trials/breast-cancer-rehabilitation-needs-and-service-uptake-30228https://curecurrent.com/trials/orin1001-in-patients-with-advanced-solid-tumors-and-relapsed-refractory-metastatic-breast-cancer-30229https://curecurrent.com/trials/tcm-as-an-adjuvant-treatment-in-breast-cancer-patients-30230https://curecurrent.com/trials/evaluating-the-efficacy-of-structured-exercise-interventions-in-alleviating-aromatase-inhibitor-induced-arthralgia-in-br-30231https://curecurrent.com/trials/lifestyles-and-breast-cancer-30232https://curecurrent.com/trials/phase-i-clinical-trials-investigating-the-potential-efficacy-of-axitinib-in-patients-with-a-brca-1-2-mutations-30233https://curecurrent.com/trials/omission-of-alnd-in-breast-cancer-patients-with-axillary-pcr-30234https://curecurrent.com/trials/assessment-of-complete-pathologic-response-after-neoadjuvant-chemotherapy-for-breast-cancer-30235https://curecurrent.com/trials/efficacy-of-the-serratus-posterior-superior-intercostal-plane-block-for-postoperative-analgesia-in-breast-cancer-surger-30236https://curecurrent.com/trials/an-escape-room-intervention-to-help-improve-breast-cancer-patients-ability-to-navigate-online-access-to-nutrition-inform-30237https://curecurrent.com/trials/a-study-of-rebastinib-dcc-2036-in-combination-with-carboplatin-in-patients-with-advanced-or-metastatic-solid-tumors-30238https://curecurrent.com/trials/aromatase-inhibitor-therapy-with-or-without-fulvestrant-for-the-treatment-of-hr-positive-metastatic-breast-cancer-with-a-30239https://curecurrent.com/trials/magnesium-sulphate-versus-ketamine-as-an-adjuvant-to-bupivacaine-in-pectoral-nerve-block-during-mastectomy-30240https://curecurrent.com/trials/percent-weight-change-in-the-medical-supplement-group-of-early-breast-cancer-30241https://curecurrent.com/trials/chidamide-combined-with-angiogenesis-inhibitors-and-fulvestrant-for-advanced-hr-positive-her2-negative-breast-cancer-30242https://curecurrent.com/trials/a-phase-1b-2-study-of-rebastinib-dcc-2036-in-combination-with-paclitaxel-in-patients-with-advanced-or-metastatic-solid-t-30243https://curecurrent.com/trials/a-phase-ii-clinical-study-to-evaluate-the-safety-pharmacokinetic-profile-and-preliminary-efficacy-of-imm2510-in-combinat-30244https://curecurrent.com/trials/oral-amxt-1501-dicaprate-in-combination-with-iv-dfmo-30245https://curecurrent.com/trials/a-phase-1-2-study-of-cyt-0851-in-b-cell-malignancies-and-advanced-solid-tumors-30246https://curecurrent.com/trials/effect-of-a-specific-hand-intervention-in-women-with-arthralgia-secondary-to-hormone-therapy-following-breast-cancer-30247https://curecurrent.com/trials/dosimetric-comparison-of-target-volume-heart-and-left-lung-in-post-mastectomy-radiotherapy-rt-of-left-sided-breast-cance-30248https://curecurrent.com/trials/chemotherapy-before-surgery-and-tissue-sample-collection-in-patients-with-stage-iia-iiic-breast-cancer-30249https://curecurrent.com/trials/pecs-block-vs-multimodal-analgesia-for-prevention-of-persistent-postoperative-pain-in-breast-surgery-30250https://curecurrent.com/trials/study-to-assess-safety-tolerability-and-clinical-activity-of-bgb-290-in-combination-with-temozolomide-tmz-in-participant-30251https://curecurrent.com/trials/super-hypofractionated-irradiation-for-whole-breast-treatment-30252https://curecurrent.com/trials/abemaciclib-palbociclib-or-dalpiciclib-combined-with-endocrine-therapy-as-first-line-treatment-in-hr-positive-her2-negat-30253https://curecurrent.com/trials/hemopatch-implication-after-axillary-dissection-for-breast-cancer-30254https://curecurrent.com/trials/role-of-mri-breast-in-detection-of-ductal-carcinoma-in-situ-30255https://curecurrent.com/trials/increasing-oral-medication-adherence-for-metastatic-breast-cancer-patients-30256https://curecurrent.com/trials/alcohol-and-breast-cancer-abc-trial-30257https://curecurrent.com/trials/study-of-shr-a1921-combined-adebrelimab-in-hr-positive-her2-negative-advanced-breast-cancer-30258https://curecurrent.com/trials/lapatinib-in-combination-with-trastuzumab-in-patients-with-her2-positive-metastatic-breast-cancer-30259https://curecurrent.com/trials/body-image-and-physical-activity-of-women-with-breast-cancer-30260https://curecurrent.com/trials/assessing-the-benefit-of-art-music-therapy-on-quality-of-life-in-patients-with-breast-cancer-30261https://curecurrent.com/trials/preoperative-boost-associated-with-neoadjuvant-chemotherapy-in-luminal-b-breast-cancer-30262https://curecurrent.com/trials/effects-of-exercise-oncology-intervention-in-fitness-capacity-and-body-composition-in-breast-cancer-survivals-30263https://curecurrent.com/trials/car-macrophages-for-the-treatment-of-her2-overexpressing-solid-tumors-30264https://curecurrent.com/trials/testing-an-active-form-of-tamoxifen-4-hydroxytamoxifen-delivered-through-breast-skin-to-control-ductal-carcinoma-in-situ-30265https://curecurrent.com/trials/study-of-pembrolizumab-in-metastatic-her2-negative-breast-cancer-patients-with-apobec3b-mutation-30266https://curecurrent.com/trials/the-registry-of-oncology-outcomes-associated-with-testing-and-treatment-30267https://curecurrent.com/trials/panther-a-study-comparing-biweekly-and-tailored-ec-t-versus-three-weekly-fec-t-in-breast-cancer-patients-30268https://curecurrent.com/trials/high-physical-activity-during-a-weight-loss-intervention-for-breast-cancer-survivors-and-high-risk-women-30269https://curecurrent.com/trials/precision-retrospective-integrative-study-for-metastatic-lymph-nodes-in-breast-cancer-30270https://curecurrent.com/trials/darsilide-combined-with-ai-trastuzumab-and-patuzumab-in-the-neoadjuvant-treatment-of-hr-her2-breast-cancer-30271https://curecurrent.com/trials/effects-of-sensorimotor-training-with-chemotherapy-induced-peripheral-neuropathy-in-breast-cancer-patients-30272https://curecurrent.com/trials/azd9833-china-pk-study-30273https://curecurrent.com/trials/a-study-on-the-efficacy-of-disitamab-vedotin-in-advanced-her2-positive-paget-s-disease-30274https://curecurrent.com/trials/testing-the-effectiveness-of-a-work-rehabilitation-intervention-for-women-with-breast-cancer-30275https://curecurrent.com/trials/famitinib-plus-shr6390-and-endocrine-therapy-in-the-treatment-of-hr-positive-her2-negative-advanced-breast-cancer-30276https://curecurrent.com/trials/axillary-sentinel-lymph-node-biopsy-after-neoadjuvant-chemotherapy-in-patients-with-initial-cn1-breast-cancer-30277https://curecurrent.com/trials/tumoral-bone-strength-assessment-by-numerical-simulation-using-quantitative-ct-the-mekanos-study-30278https://curecurrent.com/trials/metacognitive-strategy-training-in-cancer-related-cognitive-impairment-30279https://curecurrent.com/trials/bi-1607-in-combination-with-trastuzumab-in-subjects-with-her2-positive-advanced-solid-tumors-30280https://curecurrent.com/trials/named-patient-use-program-to-provide-abemaciclib-ly2835219-for-the-treatment-of-metastatic-breast-cancer-30281https://curecurrent.com/trials/anlotinib-based-combination-therapy-in-patients-with-hormone-receptor-positive-hr-metastatic-breast-cancer-mbc-30282https://curecurrent.com/trials/safety-of-pregnancy-in-brca-mutated-breast-cancer-patients-30283https://curecurrent.com/trials/safety-and-efficacy-study-of-enzalutamide-in-patients-with-advanced-androgen-receptor-positive-triple-negative-breast-ca-30284https://curecurrent.com/trials/a-phase-i-ib-study-of-nzv930-alone-and-in-combination-with-pdr001-and-or-nir178-in-patients-with-advanced-malignancies-30285https://curecurrent.com/trials/increasing-african-immigrant-women-s-participation-in-breast-cancer-screening-30286https://curecurrent.com/trials/johns-hopkins-breast-cancer-program-hormone-therapy-longitudinal-database-30287https://curecurrent.com/trials/metabolomic-evaluation-of-psycho-surgical-synergy-on-body-image-restoration-after-breast-cancer-30288https://curecurrent.com/trials/all-trans-retinoic-acid-combined-with-toripalimab-chemotherapy-for-locally-advanced-inoperable-or-metastatic-triple-nega-30289https://curecurrent.com/trials/study-to-evaluate-the-extended-overall-survival-os-data-from-parsifal-study-the-parsifal-long-study-30290https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-de-trastuzumab-t-dxd-in-combination-with-immunotherapy-for-the-neoadjuvant-30291https://curecurrent.com/trials/novel-preventive-approach-against-filgrastim-induced-bone-pain-in-cancer-patients-30292https://curecurrent.com/trials/lactobacillus-vaginalis-capsules-for-treatment-of-vulvovaginal-atrophy-in-young-breast-cancer-patients-30293https://curecurrent.com/trials/neoadjuvant-treatment-of-gbrca-mutated-her2-negative-breast-cancer-with-hrs-1167-and-famitinib-camrelizumab-30294https://curecurrent.com/trials/accelerating-the-implementation-of-a-breast-and-cervical-cancer-screening-and-hpv-vaccination-intervention-30295https://curecurrent.com/trials/salud-en-mis-manos-breast-and-cervical-cancer-prevention-and-early-detection-expansion-2-30296https://curecurrent.com/trials/electroacupuncture-combined-with-self-administered-acupressure-for-the-prevention-of-capecitabine-associated-hand-foot-s-30297https://curecurrent.com/trials/carboplatin-with-or-without-atezolizumab-in-treating-patients-with-stage-iv-triple-negative-breast-cancer-30298https://curecurrent.com/trials/increasing-access-to-fertility-preservation-for-women-with-breast-cancer-30299https://curecurrent.com/trials/jak1-inhibitor-ivarmacitinib-reversing-immunotherapy-resistance-in-tnbc-30300https://curecurrent.com/trials/study-of-preservation-of-ovarian-reserve-during-chemotherapy-for-young-breast-cancer-patients-30301https://curecurrent.com/trials/tamoxifen-for-the-prevention-of-breast-cancer-in-high-risk-women-30302https://curecurrent.com/trials/comprehensive-outcomes-for-after-cancer-health-30303https://curecurrent.com/trials/development-and-validation-of-a-personalized-digital-healthcare-model-for-managing-side-effects-in-breast-cancer-survivo-30304https://curecurrent.com/trials/pyrotinib-in-her2-positive-early-breast-cancer-30305https://curecurrent.com/trials/ovs-breast-ovarian-suppression-in-breast-cancer-interventions-30306https://curecurrent.com/trials/validity-of-brain-metastasis-risk-predictive-model-in-hormone-positive-breast-cancer-patients-30307https://curecurrent.com/trials/partial-breast-reconstruction-with-chest-wall-perforator-flap-30308https://curecurrent.com/trials/study-investigating-the-role-of-routine-screening-and-molecular-characterisation-of-brain-metastasis-in-the-management-o-30309https://curecurrent.com/trials/exercise-interventions-for-breast-cancer-patients-undergoing-neoadjuvant-chemotherapy-30310https://curecurrent.com/trials/prospective-assessment-of-acute-skin-toxicities-in-breast-cancer-patients-undergoing-retreatment-with-40-gy-in-15-fracti-30311https://curecurrent.com/trials/autoantibodies-in-breast-cancer-detection-30312https://curecurrent.com/trials/reliability-and-validity-of-ultrasound-for-the-assessment-of-soft-tissue-properties-after-breast-cancer-treatment-30313https://curecurrent.com/trials/improving-patient-understanding-of-gep-test-results-phase-4-30314https://curecurrent.com/trials/gzmb-pet-ct-to-evaluate-neoadjuvant-therapy-efficacy-in-breast-cancer-30315https://curecurrent.com/trials/next-generation-sequencing-based-oncochip-for-therapeutic-decision-in-metastatic-breast-cancer-study-sharp-30316https://curecurrent.com/trials/exercise-timing-in-breast-cancer-patients-30317https://curecurrent.com/trials/adebrelimab-plus-apatinib-and-etoposide-for-the-treatment-of-her2-negative-breast-cancer-brain-metastasis-30318https://curecurrent.com/trials/impact-of-recombinant-humanized-type-iii-collagen-on-the-immediate-and-long-term-effects-of-breast-tumor-surgery-30319https://curecurrent.com/trials/the-effect-of-breast-cancer-and-breast-self-examination-30320https://curecurrent.com/trials/treating-nectin-4-positive-advanced-breast-cancer-with-xkdct293-nectin-4-car-t-30321https://curecurrent.com/trials/canrestorefunction-cancer-related-fatigue-crf-30322https://curecurrent.com/trials/pilot-study-of-glembatumumab-vedotin-following-doxorubicin-and-cytoxan-as-neo-adjuvant-therapy-in-gp-nmb-expressing-high-30323https://curecurrent.com/trials/palbociclib-in-combination-with-fulvestrant-or-letrozole-in-patients-with-er-her2-advanced-breast-cancer-30324https://curecurrent.com/trials/her2-expression-detection-and-radionuclide-therapy-in-breast-cancer-using-99mtc-188re-labeled-single-domain-antibody-30325https://curecurrent.com/trials/a-retrospective-study-of-prognostic-factors-and-survival-of-breast-cancer-patients-with-brain-metastesis-30326https://curecurrent.com/trials/what-is-the-best-interval-to-screen-women-45-49-and-70-74-for-breast-cancer-30327https://curecurrent.com/trials/a-randomized-controlled-trial-to-increase-breast-cancer-screening-uptake-30328https://curecurrent.com/trials/four-cycles-taxane-with-trastuzumab-and-pertuzumab-neoadjuvant-therapy-among-low-risk-her2-positive-patients-30329https://curecurrent.com/trials/the-unmet-needs-of-cancer-survivors-in-ausl-irccs-reggio-emilia-30330https://curecurrent.com/trials/maximizing-benefit-of-lung-cancer-screening-incidental-findings-of-cardiovascular-respiratory-and-breast-measures-30331https://curecurrent.com/trials/chemotherapy-combined-with-targeted-therapy-for-high-risk-her2-positive-and-lymph-node-negative-early-breast-cancer-30332https://curecurrent.com/trials/dendritic-cell-vaccination-for-patients-with-solid-tumors-30333https://curecurrent.com/trials/byl719-plus-letrozole-or-exemestane-for-patients-with-hormone-receptor-positive-locally-advanced-unresectable-or-metasta-30334https://curecurrent.com/trials/a-multicenter-open-label-phase-iia-clinical-study-to-evaluate-the-efficacy-and-safety-of-b1962-injection-in-the-treatmen-30335https://curecurrent.com/trials/exercise-and-cognitive-brain-function-in-breast-cancer-patients-getting-chemotherapy-after-breast-surgery-30336https://curecurrent.com/trials/study-of-efficacy-of-ribociclib-after-progression-on-cdk4-6-inhibition-in-patients-with-hr-her2-advanced-breast-cancer-30337https://curecurrent.com/trials/trial-of-ibrutinib-plus-trastuzumab-in-her2-amplified-metastatic-breast-cancer-30338https://curecurrent.com/trials/prehabilitation-for-breast-cancer-surgery-30339https://curecurrent.com/trials/appetite-and-exercise-in-breast-cancer-survivors-30340https://curecurrent.com/trials/vaginal-co2-laser-therapy-for-genitourinary-syndrome-in-breast-cancer-survivors-30341https://curecurrent.com/trials/evaluation-of-the-effect-of-pectoral-nerve-block-ii-on-acute-and-chronic-pain-in-patients-undergoing-oncological-breast-30342https://curecurrent.com/trials/a-trial-of-early-detection-of-molecular-relapse-with-circulating-tumour-dna-tracking-and-treatment-with-palbociclib-plus-30343https://curecurrent.com/trials/ace1702-in-subjects-with-advanced-or-metastatic-her2-expressing-solid-tumors-30344https://curecurrent.com/trials/one-stage-breast-reconstruction-using-dermal-matrix-implant-versus-two-stage-expander-implant-procedure-30345https://curecurrent.com/trials/ai-model-for-classifying-breast-cancer-from-histopathology-images-30346https://curecurrent.com/trials/motivational-enhancement-therapy-to-improve-adherence-to-aromatase-inhibitors-30347https://curecurrent.com/trials/role-of-individualized-intervention-s-in-hormone-receptor-positive-early-stage-breast-cancer-30348https://curecurrent.com/trials/neoadjuvant-study-of-targeting-ros1-in-combination-with-endocrine-therapy-in-invasive-lobular-carcinoma-of-the-breast-ro-30349https://curecurrent.com/trials/facilitating-adaptive-coping-with-fear-of-recurrence-among-breast-cancer-survivors-30350https://curecurrent.com/trials/cardioprotection-with-dapagliflozin-in-breast-cancer-patients-treated-with-anthracycline-protectaa-trial-30351https://curecurrent.com/trials/mastectomy-flap-temperature-study-30352https://curecurrent.com/trials/de-escalation-adjuvant-chemo-in-her2-er-node-neg-early-bc-patients-who-achieved-pcr-after-neoadjuvant-chemo-dual-her2-bl-30353https://curecurrent.com/trials/diet-restriction-and-exercise-induced-adaptations-in-metastatic-breast-cancer-30354https://curecurrent.com/trials/a-post-market-clinical-trial-to-evaluate-the-performance-and-operation-of-the-brevera-breast-biopsy-system-30355https://curecurrent.com/trials/shr-a1811-alone-or-in-combination-with-adebrelimab-as-neoadjuvant-treatment-in-hr-positive-her2-low-breast-cancer-30356https://curecurrent.com/trials/randomized-phase-2-study-of-atezolizumab-and-entinostat-in-patients-with-atn-breast-cancer-with-phase-1b-lead-in-30357https://curecurrent.com/trials/effectiveness-of-self-physiotherapy-in-the-management-of-lymphedema-30358https://curecurrent.com/trials/comparison-of-biological-features-between-pn0-triple-negative-breast-tumours-with-size-or-10-mm-pt1a-b-versus-pt1c-t2-or-30359https://curecurrent.com/trials/treatment-resistance-following-anti-cancer-therapies-30360https://curecurrent.com/trials/a-phase-ib-ii-study-confirmed-inhibition-of-autophagy-synergizes-anti-tumor-effect-of-high-dose-cdk4-6i-30361https://curecurrent.com/trials/oxel-immune-checkpoint-or-capecitabine-or-combination-therapy-as-adjuvant-therapy-for-tnbc-with-residual-disease-30362https://curecurrent.com/trials/diagnostic-performance-of-contrast-enhanced-mammography-30363https://curecurrent.com/trials/tumor-targeted-nir-ii-fluorescent-molecular-probes-for-the-identification-of-breast-cancer-tissue-and-sln-metastatic-sta-30364https://curecurrent.com/trials/effect-of-dapaglifozin-on-myocardial-remodeling-of-breast-cancer-patients-treated-with-anthracycline-based-chemotherapy-30365https://curecurrent.com/trials/taxane-combined-targeted-therapy-for-low-risk-her2-positive-and-lymph-node-negative-breast-cancer-30366https://curecurrent.com/trials/albumin-bound-paclitaxel-dalpiciclib-and-ai-in-er-low-1-10-her2-abc-30367https://curecurrent.com/trials/adjuvant-therapy-for-intermediate-risk-her2-positive-lymph-node-negative-early-breast-cancer-with-chemotherapy-combined-30368https://curecurrent.com/trials/a-randomized-study-of-azd2014-in-combination-with-fulvestrant-in-metastatic-or-advanced-breast-cancer-30369https://curecurrent.com/trials/sbrt-chemotherapy-and-ak104-neoadjuvant-therapy-for-triple-negative-breast-cancer-tnbc-30370https://curecurrent.com/trials/magnetic-occult-lesion-localization-instrument-molli-guidance-system-for-breast-lesion-localization-30371https://curecurrent.com/trials/vocorder-device-validation-in-clinical-settings-continuous-monitoring-of-individuals-vocorder-clinical-validation-vcv-30372https://curecurrent.com/trials/serratus-anterior-plane-block-versus-serratus-posterior-superior-plane-intercostal-plane-block-for-patients-undergoing-b-30373https://curecurrent.com/trials/topical-tacrolimus-for-breast-cancer-related-lymphedema-30374https://curecurrent.com/trials/prospective-multicenter-registry-of-patients-with-skin-metastases-from-breast-cancer-treated-with-electrochemotherapy-30375https://curecurrent.com/trials/to-evaluate-the-effectiveness-and-safety-of-single-port-robotic-assisted-subcutaneous-gland-resection-combined-with-imme-30376https://curecurrent.com/trials/phase-i-study-to-evaluate-sim0270-alone-or-in-combination-in-er-her2-locally-advanced-or-metastatic-breast-cancer-30377https://curecurrent.com/trials/breast-cancer-and-breast-self-examination-education-30378https://curecurrent.com/trials/efficacy-and-safety-of-paclitaxel-polymeric-micelles-for-injection-in-the-treatment-of-metastatic-breast-cancer-30379https://curecurrent.com/trials/the-postoperative-radiotherapy-in-n1-breast-cancer-patients-30380https://curecurrent.com/trials/iort-following-breast-conserving-surgery-for-early-stage-breast-cancer-registry-30381https://curecurrent.com/trials/short-course-trastuzumab-pertuzumab-with-taxanes-in-the-adjuvant-treatment-of-early-her2-positive-breast-cancer-30382https://curecurrent.com/trials/trial-of-zw25-zanidatamab-in-patients-with-advanced-her2-expressing-cancers-30383https://curecurrent.com/trials/vaginal-dehydroepiandrosterone-dhea-in-postmenopausal-breast-cancer-survivors-on-aromatase-inhibitors-30384https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-chemotherapy-vs-placebo-plus-chemotherapy-for-previously-untreated-locally-recurrent-30385https://curecurrent.com/trials/role-of-mri-in-breast-cancer-subtypes-30386https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-women-with-hr-her2-locally-advanced-or-metastatic-breast-cancer-30387https://curecurrent.com/trials/effectiveness-of-aquatic-exercise-on-fatigue-neuropathy-and-quality-of-life-among-cancer-patients-30388https://curecurrent.com/trials/feasibility-and-effectiveness-of-an-internet-based-intervention-to-manage-fatigue-in-breast-cancer-survivors-30389https://curecurrent.com/trials/pharmacokinetics-and-pharmacogenomics-of-ribociclib-in-race-based-cohorts-30390https://curecurrent.com/trials/tislelizumab-combined-with-nab-paclitaxel-for-first-line-treatment-of-advanced-triple-negative-breast-cancer-with-bone-m-30391https://curecurrent.com/trials/feasibility-and-effectiveness-of-a-sleep-hygiene-education-program-for-sleep-issues-in-breast-cancer-survivors-30392https://curecurrent.com/trials/radiotherapy-followed-by-chemotherapy-combined-with-toripalimab-in-local-advanced-hr-positive-her2-negative-bc-30393https://curecurrent.com/trials/a-real-world-study-of-effectiveness-and-safety-in-hr-her2-breast-cancer-patients-treated-with-ribociclib-or-alpelisib-30394https://curecurrent.com/trials/study-of-hrs-8080-or-shr-a2009-combined-with-anti-tumor-therapy-in-patients-with-unresectable-or-metastatic-breast-cance-30395https://curecurrent.com/trials/defining-the-clinical-potential-of-mass-response-as-a-biomarker-for-patient-tumor-sensitivity-to-drugs-30396https://curecurrent.com/trials/sentinel-node-vs-observation-after-axillary-ultra-sound-30397https://curecurrent.com/trials/study-of-imm-101-in-combination-with-standard-of-care-in-patients-with-metastatic-or-unresectable-cancer-30398https://curecurrent.com/trials/organoid-based-functional-precision-therapy-for-advanced-breast-cancer-30399https://curecurrent.com/trials/de-escalation-of-neoadjuvant-chemotherapy-regimens-with-targeted-therapy-among-her2-positive-patients-30400https://curecurrent.com/trials/patient-reported-outcome-and-safety-between-preoperative-and-postmastectomy-radiotherapy-in-diep-flap-reconstruction-30401https://curecurrent.com/trials/different-methods-of-capecitabine-in-patients-with-non-pcr-after-neoadjuvant-therapy-for-tnbc-30402https://curecurrent.com/trials/anonymous-survey-of-breast-cancer-patients-concerning-their-use-of-medical-apps-30403https://curecurrent.com/trials/fpa150-in-patients-with-advanced-solid-tumors-30404https://curecurrent.com/trials/primary-hormone-sensitive-breast-cancer-need-driven-health-care-improvement-by-patient-centred-digital-application-30405https://curecurrent.com/trials/study-to-evaluate-patient-reported-outcome-pro-and-physical-activity-in-japanese-patients-with-hr-her2-advanced-breast-c-30406https://curecurrent.com/trials/effectiveness-of-a-modern-educational-intervention-in-breast-cancer-patients-30407https://curecurrent.com/trials/ribociclib-in-combination-with-adjuvant-endocrine-therapy-for-patients-with-early-high-risk-hr-her2-breast-cancer-30408https://curecurrent.com/trials/effects-of-a-combined-program-of-pelvic-floor-muscle-training-and-yoga-30409https://curecurrent.com/trials/autologous-tumor-infiltrating-lymphocytes-in-patients-with-pretreated-metastatic-triple-negative-breast-cancer-30410https://curecurrent.com/trials/the-association-between-plasma-metabolites-and-the-risk-efficacy-and-prognosis-in-early-breast-cancer-30411https://curecurrent.com/trials/homologous-recombination-inquiry-through-ovarian-malignancy-investigations-30412https://curecurrent.com/trials/study-of-intermittent-osi-906-dosing-30413https://curecurrent.com/trials/amyloid-plaque-deposition-in-chemotherapy-induced-cognitive-impairment-30414https://curecurrent.com/trials/a-study-to-find-the-best-dose-of-asp5354-to-show-lymph-nodes-in-people-with-breast-cancer-or-melanoma-during-surgery-30415https://curecurrent.com/trials/imaging-patients-for-cancer-drug-selection-metastatic-breast-cancer-30416https://curecurrent.com/trials/study-of-continuous-osi-906-dosing-30417https://curecurrent.com/trials/safety-and-efficacy-of-durvalumab-combined-to-neoadjuvant-chemotherapy-in-localized-luminal-b-her2-and-triple-negative-b-30418https://curecurrent.com/trials/de-escalation-of-neoadjuvant-chemotherapy-regimens-with-immunotherapy-among-tnbc-30419https://curecurrent.com/trials/neoadjuvant-chemoradiotherapy-compared-to-neoadjuvant-chemotherapy-for-luminal-type-locally-advanced-breast-cancer-a-cli-30420https://curecurrent.com/trials/efficacy-and-safety-of-hyperbaric-oxygen-therapy-for-radiation-dermatitis-in-patients-with-localized-breast-cancer-30421https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-multiple-doses-of-enzalutamide-on-the-pharmacokinetics-of-substrates-of-p-glycoprotein-30422https://curecurrent.com/trials/adjuvant-therapy-choice-for-non-pcr-her2-positive-early-breast-cancer-after-neoadjuvant-therapy-30423https://curecurrent.com/trials/adjuvant-therapy-with-neratinib-in-her2-positive-early-breast-cancer-30424https://curecurrent.com/trials/stick-together-pilot-intervention-study-30425https://curecurrent.com/trials/liposomal-bupivacaine-vs-bupivacaine-with-dexmedetomidine-in-erector-spinae-plane-blocks-for-mastectomies-30426https://curecurrent.com/trials/artificial-intelligence-supporting-cancer-patients-across-europe-the-ascape-project-30427https://curecurrent.com/trials/the-clinical-trial-of-tqb2102-for-injection-against-human-epidermal-growth-factor-receptor-2-negative-breast-cancer-30428https://curecurrent.com/trials/effect-of-intravaginal-prasterone-on-symptoms-of-genitourinary-syndrome-of-menopause-gsm-in-women-in-menopause-with-prev-30429https://curecurrent.com/trials/the-effects-of-her2-receptor-signaling-on-human-brown-fat-activity-30430https://curecurrent.com/trials/single-pre-operative-radiation-therapy-with-delayed-or-no-surgery-sport-dns-30431https://curecurrent.com/trials/brief-intervention-for-tobacco-and-alcohol-risk-reduction-for-couple-during-breast-cancer-treatment-30432https://curecurrent.com/trials/implementing-geriatric-assessment-for-dose-optimization-of-cyclin-dependent-kinase-cdk-4-6-inhibitors-in-older-breast-ca-30433https://curecurrent.com/trials/galinpepimut-s-in-combination-with-pembrolizumab-in-patients-with-selected-advanced-cancers-30434https://curecurrent.com/trials/ro4929097-and-whole-brain-radiation-therapy-or-stereotactic-radiosurgery-in-treating-patients-with-brain-metastases-from-30435https://curecurrent.com/trials/single-pre-operative-radiation-therapy-with-delayed-surgery-for-low-risk-breast-cancer-30436https://curecurrent.com/trials/axillary-lns-evalution-in-breast-cancer-by-multimodal-us-30437https://curecurrent.com/trials/feasibility-of-addressing-sexual-dysfunction-in-women-with-breast-and-gynecologic-cancers-with-a-novel-mobile-applicatio-30438https://curecurrent.com/trials/a-study-of-xl092-as-single-agent-and-combination-therapy-in-subjects-with-solid-tumors-30439https://curecurrent.com/trials/pembrolizumab-and-oral-metronomic-cyclophosphamide-in-patients-with-chest-wall-breast-cancer-30440https://curecurrent.com/trials/a-pk-study-testing-single-oral-dose-of-elacestrant-in-subjects-with-normal-or-severely-impaired-hepatic-function-30441https://curecurrent.com/trials/optitrain-optimal-training-women-with-breast-cancer-30442https://curecurrent.com/trials/exercise-as-medicine-for-people-with-cancer-sweden-30443https://curecurrent.com/trials/combination-of-olaparib-and-navitoclax-in-women-with-hgsc-and-tnbc-30444https://curecurrent.com/trials/the-impact-of-radiotherapy-on-oligometastatic-cancer-30445https://curecurrent.com/trials/sensorimotor-training-using-whole-body-vibration-exercise-to-reduce-chemotherapy-induced-peripheral-neuropathy-30446https://curecurrent.com/trials/phase-1-dose-escalation-study-for-vip236-in-patients-with-advanced-cancer-30447https://curecurrent.com/trials/phase-i-dose-escalation-study-for-vip152-in-patients-with-advanced-cancer-30448https://curecurrent.com/trials/effect-of-planned-education-on-health-beliefs-and-fatalism-in-women-at-high-risk-of-breast-cancer-30449https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-dosimetry-of-68ga-labelled-oncofap-derivatives-in-solid-tumors-30450https://curecurrent.com/trials/the-association-of-psychological-stress-with-the-efficacy-of-neoadjuvant-therapy-in-breast-cancer-30451https://curecurrent.com/trials/phase-1a-and-phase-2-study-for-safety-preliminary-efficacy-pk-and-pd-of-st-067-30452https://curecurrent.com/trials/fulvestrant-palbociclib-and-erdafitinib-in-er-her2-fgfr-amplified-metastatic-breast-cancer-30453https://curecurrent.com/trials/a-study-of-palbociclib-pd-0332991-letrozole-vs-letrozole-for-1st-line-treatment-of-postmenopausal-women-with-er-her2-adv-30454https://curecurrent.com/trials/evaluation-of-postoperative-neurocognitive-impairment-30455https://curecurrent.com/trials/intraoperative-evaluation-of-axillary-lymphatics-30456https://curecurrent.com/trials/a-study-to-learn-about-the-vepdegestrant-arv-471-pf-07850327-in-people-with-er-her2-locally-advanced-or-metastatic-breas-30457https://curecurrent.com/trials/the-4d-picture-project-evaluating-metro-mapping-as-a-method-to-support-shared-decision-making-in-oncology-30458https://curecurrent.com/trials/gisel-registry-of-breast-cancer-patients-treated-with-ect-30459https://curecurrent.com/trials/studying-the-senescent-t-cell-features-and-its-relationship-with-the-chemotherapy-efficacy-in-young-tnbc-30460https://curecurrent.com/trials/til-gean-therapy-combined-with-immunotherapy-for-advanced-or-metastatic-refractory-breast-cancer-30461https://curecurrent.com/trials/mhealth-behavioural-intervention-to-increase-breast-cancer-screening-rates-among-members-of-the-public-30462https://curecurrent.com/trials/a-study-of-ipatasertib-plus-palbociclib-and-fulvestrant-versus-placebo-plus-palbociclib-and-fulvestrant-in-hormone-recep-30463https://curecurrent.com/trials/neoadjuvant-phase-ii-trial-in-patients-with-t1c-operable-her2-positive-breast-cancer-according-to-top2a-status-30464https://curecurrent.com/trials/onset-of-sensory-block-after-thoracic-esp-block-30465https://curecurrent.com/trials/lymphovenous-anastomosis-to-prevent-breast-cancer-related-lymphedema-30466https://curecurrent.com/trials/an-observational-study-of-patients-receiving-t-dxd-for-treatment-of-her2-and-her2-low-unresectable-and-or-metastatic-bre-30467https://curecurrent.com/trials/survey-study-financial-impact-of-breast-cancer-treatment-30468https://curecurrent.com/trials/the-effect-of-memantine-on-the-prevention-and-amelioration-of-paclitaxel-induced-toxicity-in-breast-cancer-patients-30469https://curecurrent.com/trials/aurora-a-human-centered-program-for-breast-cancer-patients-in-chile-easing-neoadjuvant-chemotherapy-s-effects-30470https://curecurrent.com/trials/cdk4-6-inhibitor-or-chemotherapy-in-combination-with-endocrine-therapy-for-advanced-breast-cancer-kendo-30471https://curecurrent.com/trials/apbi-proton-feasibility-and-phase-ii-study-30472https://curecurrent.com/trials/clinical-trial-of-eribulin-in-combination-with-anrotinib-for-her-2-negative-locally-advanced-or-metastatic-breast-cancer-30473https://curecurrent.com/trials/persistent-organic-pollutants-and-breast-cancers-popcase-30474https://curecurrent.com/trials/preoperative-partial-breast-irradiation-in-early-stage-breast-cancer-30475https://curecurrent.com/trials/vaccination-of-triple-negative-breast-cancer-patients-30476https://curecurrent.com/trials/evaluating-illustrated-vs-traditional-pamphlets-for-enhancing-self-care-in-radiation-therapy-patients-30477https://curecurrent.com/trials/palbociclib-letrozole-venetoclax-in-er-and-bcl-2-positive-breast-cancer-30478https://curecurrent.com/trials/the-in4m-study-integrating-4-methods-to-assess-physical-function-in-cancer-patients-30479https://curecurrent.com/trials/outcomes-of-a-novel-technique-minimal-scar-mastectomy-30480https://curecurrent.com/trials/arry-380-trastuzuamab-for-breast-w-brain-mets-30481https://curecurrent.com/trials/eribulin-in-her2-negative-metastatic-brca-30482https://curecurrent.com/trials/a-phase-iii-trial-to-compare-the-efficacy-safety-and-pharmacokinetics-of-hd201-to-herceptin-in-her2-early-breast-cancer-30483https://curecurrent.com/trials/transcutaneous-electrical-acupoint-stimulation-on-symptoms-associated-with-chemotherapy-induced-peripheral-neuropathy-30484https://curecurrent.com/trials/improvement-of-quality-of-life-through-supportive-treatments-for-hormone-therapy-related-symptoms-in-patients-with-early-30485https://curecurrent.com/trials/cooling-cap-trial-to-prevent-permanent-chemotherapy-induced-alopecia-in-breast-cancer-patients-30486https://curecurrent.com/trials/physical-activity-promotion-in-breast-cancer-survivors-30487https://curecurrent.com/trials/first-time-in-human-study-of-azd8701-with-or-without-durvalumab-in-participants-with-advanced-solid-tumours-30488https://curecurrent.com/trials/effects-of-aerobic-exercise-versus-weight-training-in-breast-cancer-survivors-during-chemotherapy-30489https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-atezolizumab-or-placebo-in-combination-with-neoadjuvant-doxorubicin-cyclo-30490https://curecurrent.com/trials/adjuvant-metronomic-capecitabine-plus-endocrine-therapy-for-hr-her2-primary-breast-cancer-30491https://curecurrent.com/trials/the-influence-of-physical-activity-on-the-health-and-well-being-of-breast-cancer-survivors-30492https://curecurrent.com/trials/a-study-of-shr-a1811-as-neoadjuvant-treatment-for-patients-with-hr-positive-low-her2-expression-breast-cancer-30493https://curecurrent.com/trials/comparing-the-safety-and-cosmetic-outcomes-between-laparoscopic-versus-traditional-open-breast-conserving-surgery-30494https://curecurrent.com/trials/parpi-or-capecitabine-combined-with-pd-1-inhibitors-as-adjuvant-therapy-in-high-risk-tnbc-30495https://curecurrent.com/trials/reduction-of-pre-operative-anxiety-using-a-specially-designed-educational-program-for-breast-cancer-patients-undergoing-30496https://curecurrent.com/trials/effect-of-aprepitant-on-cyclophosphamide-pharmacokinetics-in-patients-with-breast-cancer-30497https://curecurrent.com/trials/near-infrared-spectroscopy-nirs-as-a-method-for-measuring-oxidative-capacity-of-skeletal-muscle-mitochondria-in-breast-c-30498https://curecurrent.com/trials/the-effect-of-arm-exercises-on-arm-oedema-after-breast-cancer-surgery-30499https://curecurrent.com/trials/a-phase-i-dose-escalation-trial-of-definitive-single-dose-stereotactic-body-radiotherapy-in-low-risk-breast-cancer-patie-30500https://curecurrent.com/trials/study-of-radiation-fractionation-on-patient-outcomes-after-breast-reconstruction-fabrec-for-invasive-breast-carcinoma-30501https://curecurrent.com/trials/investigating-paclitaxel-toxicity-in-breast-cancer-the-roles-of-physical-activity-and-body-composition-30502https://curecurrent.com/trials/invest-gat-on-of-temporomand-bular-dysfunct-on-in-pat-ents-w-th-breast-cancer-related-lymphedema-30503https://curecurrent.com/trials/a-study-of-asp1948-targeting-an-immune-modulatory-receptor-as-a-single-agent-and-in-combination-with-a-pd-l-inhibitor-ni-30504https://curecurrent.com/trials/study-on-sleep-lifestyle-and-quality-of-life-in-women-with-breast-cancer-30505https://curecurrent.com/trials/cognitive-impairment-in-treated-breast-cancer-survivors-possible-approaches-30506https://curecurrent.com/trials/phase-i-ii-study-of-u3-1402-in-subjects-with-human-epidermal-growth-factor-receptor-3-her3-positive-metastatic-breast-ca-30507https://curecurrent.com/trials/imm2902-a-her2-sirp-bispecific-mab-trap-antibody-receptor-fusion-protein-in-patients-with-her2-expressing-advanced-solid-30508https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-ipatasertib-in-combination-with-atezolizumab-and-paclitaxel-or-nab-paclit-30509https://curecurrent.com/trials/a-study-of-arx788-combined-with-pyrotinib-maleate-versus-tcbhp-trastuzumab-plus-pertuzumab-with-docetaxel-and-carboplati-30510https://curecurrent.com/trials/arx788-in-her2-positive-metastatic-breast-cancer-patients-30511https://curecurrent.com/trials/a-study-of-ni-1801-in-patients-with-mesothelin-expressing-solid-cancers-30512https://curecurrent.com/trials/project-breast47-effect-of-an-educational-intervention-30513https://curecurrent.com/trials/rapid-histologic-assessment-for-stereotactic-breast-biopsy-enhancing-early-detection-with-miniature-mass-spectrometry-an-30514https://curecurrent.com/trials/the-effect-of-digital-technology-supported-education-on-patients-undergoing-breast-reconstruction-after-mastectomy-a-ran-30515https://curecurrent.com/trials/large-segmentation-radiotherapy-deep-inspiration-breath-hold-dibh-for-left-breast-cancer-30516https://curecurrent.com/trials/a-study-of-ly3022855-in-participants-with-breast-or-prostate-cancer-30517https://curecurrent.com/trials/18f-fluoroestradiol-pet-ct-companion-imaging-study-to-the-foresee-trial-30518https://curecurrent.com/trials/a-phase-i-trial-of-cct303-406-in-patients-with-relapsed-or-refractory-her2-positive-solid-tumors-30519https://curecurrent.com/trials/functional-precision-oncology-for-metastatic-breast-cancer-30520https://curecurrent.com/trials/efficacy-and-safety-of-bgb-290-in-the-treatment-of-metastatic-her2-negative-breast-cancer-patients-with-brca-mutation-in-30521https://curecurrent.com/trials/using-an-adjustable-compression-garment-for-secondary-upper-limb-lymphoedema-30522https://curecurrent.com/trials/panitumumab-and-pembrolizumab-in-combination-with-neoadjuvant-chemotherapy-for-the-treatment-of-stage-iii-iv-triple-nega-30523https://curecurrent.com/trials/efficacy-and-safety-of-ribociclib-combined-with-ai-versus-physician-amp-39-s-choice-of-chemotherapy-sequential-endocrine-30524https://curecurrent.com/trials/one-week-versus-three-week-in-adjuvant-radiotherapy-in-breast-cancer-30525https://curecurrent.com/trials/effects-of-vaginal-estrogen-on-serum-estradiol-during-aromatase-inhibitor-therapy-in-breast-cancer-patients-with-vulvova-30526https://curecurrent.com/trials/intelligent-vacuum-assisted-biopsy-immediately-before-surgery-as-an-intra-or-pre-operative-surrogate-for-patient-respons-30527https://curecurrent.com/trials/efficacy-and-safety-of-a-two-week-dosing-regimen-of-vinorelbine-combined-with-liposomal-doxorubicin-in-the-treatment-of-30528https://curecurrent.com/trials/a-study-of-pre-operative-treatment-with-cryoablation-and-immune-therapy-in-early-stage-breast-cancer-30529https://curecurrent.com/trials/digital-cognitive-behavioral-therapy-for-insomnia-for-chronic-insomnia-in-breast-cancer-survivors-30530https://curecurrent.com/trials/m7824-in-treating-patients-with-stage-ii-iii-her2-positive-breast-cancer-30531https://curecurrent.com/trials/improving-uptake-of-genetic-cancer-risk-assessment-in-african-american-women-video-30532https://curecurrent.com/trials/a-feasibility-and-acceptability-pilot-study-evaluating-a-patient-specific-targeted-intervention-using-patient-navigators-30533https://curecurrent.com/trials/monalizumab-and-trastuzumab-in-metastatic-her2-positive-breast-cancer-mimosa-trial-30534https://curecurrent.com/trials/the-rechallenge-of-adcs-in-mbc-patients-30535https://curecurrent.com/trials/study-of-sacituzumab-govitecan-hziy-versus-treatment-of-physician-s-choice-in-participants-with-hr-her2-metastatic-breas-30536https://curecurrent.com/trials/study-of-the-safety-pharmacokinetics-and-efficacy-of-tinostamustine-in-patients-with-advanced-solid-tumors-30537https://curecurrent.com/trials/quilting-sutures-after-mastectomy-30538https://curecurrent.com/trials/evaluation-of-the-bexa-breast-examination-30539https://curecurrent.com/trials/task-oriented-training-on-hand-function-in-taxanes-induced-peripheral-neuropathy-30540https://curecurrent.com/trials/a-tele-exercise-program-for-breast-cancer-survivors-30541https://curecurrent.com/trials/molecular-biomarkers-of-response-to-radiation-therapy-in-breast-cancer-30542https://curecurrent.com/trials/lllt-for-bcrl-a-randomized-placebo-controlled-study-30543https://curecurrent.com/trials/prospective-validation-and-application-of-an-artificial-intelligence-based-model-for-evaluating-the-efficacy-of-breast-c-30544https://curecurrent.com/trials/analysis-of-olaparib-response-in-patients-with-brca1-and-or-2-promoter-methylation-diagnosed-of-advanced-breast-cancer-30545https://curecurrent.com/trials/chronic-toxicities-related-to-treatment-in-patients-with-localized-cancer-30546https://curecurrent.com/trials/a-prospective-study-to-evaluate-clinical-performance-of-thermalytix-in-detecting-breast-cancers-30547https://curecurrent.com/trials/cellular-immune-responses-in-triple-negative-breast-cancer-high-throughput-immunogenetic-studies-30548https://curecurrent.com/trials/milademetan-in-advanced-metastatic-solid-tumors-30549https://curecurrent.com/trials/evaluation-of-needle-core-biopsy-of-axillary-sentinel-lymph-node-in-breast-cancer-30550https://curecurrent.com/trials/remote-monitoring-of-patient-reported-outcomes-to-improve-the-efficacy-of-the-acute-phase-radiotherapy-review-process-30551https://curecurrent.com/trials/a-culturally-sensitive-social-support-intervention-30552https://curecurrent.com/trials/effectiveness-of-an-n-acetylcysteine-and-urea-based-cream-in-prevention-of-capecitabine-induced-hand-foot-syndrome-in-br-30553https://curecurrent.com/trials/does-type-of-anesthesia-influence-inflammation-change-after-breast-surgery-30554https://curecurrent.com/trials/rankl-inhibition-and-breast-tissue-biomarkers-30555https://curecurrent.com/trials/genetics-and-heart-health-after-cancer-therapy-30556https://curecurrent.com/trials/non-mass-enhancement-in-breast-mri-30557https://curecurrent.com/trials/laser-treatment-of-genito-urinary-syndrome-in-women-30558https://curecurrent.com/trials/targeted-biopsy-of-carbon-nanoparticles-labelled-axillary-node-for-cn-breast-cancer-30559https://curecurrent.com/trials/atezolizumab-combined-with-immunogenic-chemotherapy-in-patients-with-metastatic-triple-negative-breast-cancer-30560https://curecurrent.com/trials/neoadjuvant-chemotherapy-pd-1-inhibitor-different-radiotherapy-fractionations-for-hr-her2-breast-cancer-30561https://curecurrent.com/trials/swebcg-91-a-rt-breast-conserving-surgery-with-or-without-radiotherapy-for-breast-cancer-patients-30562https://curecurrent.com/trials/beat-breast-trial-of-de-iptv-in-patients-with-primary-breast-cancer-with-brain-metastases-who-are-not-suitable-for-stere-30563https://curecurrent.com/trials/phase-iib-study-evaluating-immunogenic-chemotherapy-combined-with-ipilimumab-and-nivolumab-in-breast-cancer-30564https://curecurrent.com/trials/study-of-jk08-in-patients-with-unresectable-locally-advanced-or-metastatic-cancer-30565https://curecurrent.com/trials/enhancing-therapy-adherence-among-metastatic-breast-cancer-patients-30566https://curecurrent.com/trials/intraoperative-radiotherapy-for-early-stage-breast-cancer-30567https://curecurrent.com/trials/randomized-phase-ii-trial-chest-wall-rt-omission-after-prosthetic-reconstruction-30568https://curecurrent.com/trials/omission-of-slnb-in-cn0-early-breast-cancer-30569https://curecurrent.com/trials/the-efficacy-and-safety-of-different-combination-regimens-of-inetetamab-in-first-line-treatment-of-her2-positive-metasta-30570https://curecurrent.com/trials/clinical-study-of-vaginal-lactobacilli-and-estriol-gynoflor-for-atrophic-vaginitis-in-breast-cancer-patients-30571https://curecurrent.com/trials/clinical-classification-of-pain-in-breast-cancer-survivors-30572https://curecurrent.com/trials/ai-based-skeleton-recognition-system-for-rehabilitation-exercise-in-breast-cancer-survivors-a-randomized-controlled-tria-30573https://curecurrent.com/trials/perioperative-mindfulness-proposal-30574https://curecurrent.com/trials/sbrt-and-oncolytic-virus-therapy-before-pembrolizumab-for-metastatic-tnbc-and-nsclc-30575https://curecurrent.com/trials/mammogram-mail-and-phone-based-interventions-30576https://curecurrent.com/trials/phi-to-solid-tumors-and-phii-to-locally-advanced-or-mtnbc-30577https://curecurrent.com/trials/gb491-combined-with-fulvestrant-for-hr-her2-locally-advanced-or-metastatic-breast-cancer-30578https://curecurrent.com/trials/telephone-support-for-metastatic-breast-cancer-patients-30579https://curecurrent.com/trials/alpelisib-and-enzalutamide-in-treating-patients-with-androgen-receptor-and-pten-positive-metastatic-breast-cancer-30580https://curecurrent.com/trials/the-effects-of-a-nurse-led-mhealth-program-for-symptom-self-management-of-breast-cancer-patients-undergoing-chemotherapy-30581https://curecurrent.com/trials/massive-open-online-course-mooc-for-women-with-breast-cancer-30582https://curecurrent.com/trials/study-of-ngm831-as-monotherapy-and-in-combination-with-pembrolizumab-or-pembrolizumab-and-ngm438-in-advanced-or-metastat-30583https://curecurrent.com/trials/the-safety-and-efficacy-of-multimodal-thermal-therapy-in-the-treatment-of-early-stage-invasive-breast-cancer-30584https://curecurrent.com/trials/study-to-compare-the-combination-of-ribociclib-plus-goserelin-acetate-with-hormonal-therapy-versus-combination-chemother-30585https://curecurrent.com/trials/mri-guided-ultrasound-stimulated-microbubbles-radiation-treatment-for-patients-with-chest-wall-and-locally-advanced-brea-30586https://curecurrent.com/trials/evaluation-of-cryoprotection-induced-nail-toxicity-docetaxel-low-cumulative-dose-30587https://curecurrent.com/trials/the-effect-of-health-education-on-breast-cancer-30588https://curecurrent.com/trials/study-to-compare-alisertib-with-paclitaxel-vs-paclitaxel-alone-in-metastatic-or-locally-recurrent-breast-cancer-30589https://curecurrent.com/trials/study-of-safety-and-efficacy-of-dapagliflozin-metformin-xr-versus-metformin-xr-in-participants-with-hr-her2-advanced-bre-30590https://curecurrent.com/trials/ai-assisted-non-contrast-ct-for-multi-cancer-screening-30591https://curecurrent.com/trials/a-phase-2-study-of-nir178-in-combination-with-pdr001-in-patients-with-solid-tumors-and-non-hodgkin-lymphoma-30592https://curecurrent.com/trials/comparative-real-world-tumor-response-in-pre-menopausal-metastatic-breast-cancer-patients-treated-with-palbociclib-aroma-30593https://curecurrent.com/trials/effect-of-neoadjuvant-chemoradiation-on-pathologic-complete-response-rates-in-locally-advanced-breast-cancer-patients-30594https://curecurrent.com/trials/pain-control-in-breast-surgery-analgesia-opioid-consumption-and-inflammatory-response-evaluation-30595https://curecurrent.com/trials/evaluating-the-impact-of-financial-navigation-on-financial-catastrophe-and-distress-for-cancer-care-30596https://curecurrent.com/trials/vitamin-d-and-breast-cancer-biomarkers-in-female-patients-30597https://curecurrent.com/trials/positive-er-expression-assessed-by-18f-fes-pet-ct-in-the-mbc-with-er-negative-primary-tumor-30598https://curecurrent.com/trials/brevera-breast-biopsy-system-data-collection-study-30599https://curecurrent.com/trials/autologous-nerve-graft-breast-reconstruction-neurotization-30600https://curecurrent.com/trials/lumpectomy-followed-by-intraoperative-electron-radiation-therapy-ioert-30601https://curecurrent.com/trials/observational-retrospective-study-to-assess-the-use-of-ribociclib-in-patients-with-hr-her2-metastatic-breast-cancer-trea-30602https://curecurrent.com/trials/adjustable-compression-wrap-versus-compression-bandage-reduce-to-breast-cancer-related-lymphedema-30603https://curecurrent.com/trials/cognitive-dysfunction-and-breast-cancer-coping-strategies-impact-on-qol-30604https://curecurrent.com/trials/rw-treatment-patterns-and-outcomes-in-postmenopausal-hr-her2-mbc-patients-treated-with-palbociclib-plus-letrozole-as-ini-30605https://curecurrent.com/trials/snf-platform-study-of-hr-her2-advanced-breast-cancer-30606https://curecurrent.com/trials/evaluation-of-skin-health-and-qol-in-pts-receiving-anti-pd1-pdl1-ctla4-or-cdk-inhibitors-30607https://curecurrent.com/trials/patient-registry-partial-breast-irradiation-30608https://curecurrent.com/trials/effects-of-yoga-on-women-with-breast-cancer-30609https://curecurrent.com/trials/assessment-of-oncological-safety-quality-of-life-and-environmental-impact-of-the-green-breast-surgery-protocol-30610https://curecurrent.com/trials/a-crossover-bioequivalence-study-of-olaparib-tablets-150-mg-lek-pharmaceuticals-d-d-and-lynparza-olaparib-tablets-150-mg-30611https://curecurrent.com/trials/window-of-opportunity-trial-parp-inhibitor-rucaparib-affect-on-pd-l1-expression-in-triple-negative-breast-tumors-30612https://curecurrent.com/trials/the-control-trial-cryotherapy-vs-compression-neuropathy-trial-30613https://curecurrent.com/trials/exercise-in-older-women-with-breast-cancer-during-systemic-therapy-30614https://curecurrent.com/trials/diet-effect-on-cancer-treatment-outcome-30615https://curecurrent.com/trials/atorvastatin-in-treating-patients-with-stage-iib-iii-triple-negative-breast-cancer-who-did-not-achieve-a-pathologic-comp-30616https://curecurrent.com/trials/dietary-restriction-to-prevent-cardiotoxicity-in-breast-cancer-patients-30617https://curecurrent.com/trials/study-of-ngm707-as-monotherapy-and-in-combination-with-pembrolizumab-in-advanced-or-metastatic-solid-tumor-malignancies-30618https://curecurrent.com/trials/early-changes-in-metabolic-health-in-breast-cancer-patients-initiating-endocrine-therapy-30619https://curecurrent.com/trials/knuch-cadai-b-1-kcb-1-30620https://curecurrent.com/trials/exercise-program-on-pain-physical-function-and-quality-of-life-in-breast-cancer-survivors-30621https://curecurrent.com/trials/radiation-therapy-during-surgery-in-treating-older-women-with-invasive-breast-cancer-30622https://curecurrent.com/trials/a-randomized-open-label-multi-center-phase-iv-study-evaluating-palbociclib-plus-endocrine-treatment-versus-a-chemotherap-30623https://curecurrent.com/trials/retrospective-observational-study-of-the-safety-and-toxicity-management-of-abemaciclib-in-combination-with-adjuvant-horm-30624https://curecurrent.com/trials/erector-spinae-plane-block-versus-serratus-anterior-block-on-post-mastectomy-pain-syndrome-30625https://curecurrent.com/trials/evaluation-of-the-impact-of-taking-american-ginseng-for-8-weeks-on-fatigue-in-patients-treated-for-localized-breast-or-g-30626https://curecurrent.com/trials/imaging-markers-of-subclinical-cardiotoxicity-in-breast-cancer-30627https://curecurrent.com/trials/assessment-of-99mtc-ntp-15-5-uptake-on-cartilage-a-new-proteoglycan-tracer-30628https://curecurrent.com/trials/improving-genetic-counseling-for-brca-mothers-30629https://curecurrent.com/trials/novel-thermal-imaging-technique-for-breast-screening-30630https://curecurrent.com/trials/combination-of-hx008-and-niraparib-in-germ-line-mutated-metastatic-breast-cancer-30631https://curecurrent.com/trials/a-parg-inhibitor-dat-2645-monotherapy-in-patients-with-advanced-metastatic-solid-tumors-harboring-brca1-2-loss-of-functi-30632https://curecurrent.com/trials/contrast-enhanced-spectral-mammography-cesm-early-quantitative-evaluation-of-tumoral-response-and-pathologic-complete-re-30633https://curecurrent.com/trials/a-first-in-human-study-of-bay2701439-to-look-at-safety-how-the-body-absorbs-distributes-and-excretes-the-drug-and-how-we-30634https://curecurrent.com/trials/compare-the-efficacy-and-safety-of-ql0605-injections-at-different-timepoints-30635https://curecurrent.com/trials/novel-magnetic-resonance-imaging-guided-ultrasound-stimulated-microbubble-radiation-treatment-for-patients-with-chest-wa-30636https://curecurrent.com/trials/lipidomic-characterization-in-non-metastatic-breast-cancer-women-undergoing-surgery-a-pilot-study-30637https://curecurrent.com/trials/a-study-of-anti-pd-l1-checkpoint-antibody-ly3300054-alone-and-in-combination-in-participants-with-advanced-refractory-so-30638https://curecurrent.com/trials/pipa-combination-of-pi3-kinase-inhibitors-and-palbociclib-30639https://curecurrent.com/trials/super-hypofractionated-partial-breast-irradiation-30640https://curecurrent.com/trials/safety-effectiveness-and-quality-of-life-of-trastuzumab-deruxtecan-in-patients-with-her2-breast-cancer-30641https://curecurrent.com/trials/a-bioequivalence-study-between-the-proposed-and-current-talazoparib-capsule-formulation-and-food-effect-study-for-the-pr-30642https://curecurrent.com/trials/a-multi-center-open-label-study-of-fruquintinib-in-solid-tumors-and-colorectal-and-breast-cancers-30643https://curecurrent.com/trials/parp-inhibitor-with-cdk4-6-inhibitor-and-endocrine-therapy-in-hr-her2-advanced-breast-cancer-30644https://curecurrent.com/trials/phase-iii-palbociclib-with-endocrine-therapy-vs-capecitabine-in-hr-her2-mbc-with-resistance-to-aromatase-inhibitors-30645https://curecurrent.com/trials/an-exploratory-clinical-study-of-cdk4-6i-dalpiciclib-combined-with-ai-neoadjuvant-therapy-for-stage-ii-iii-hr-her2-breas-30646https://curecurrent.com/trials/pilot-study-of-financial-navigation-program-for-improving-financial-toxicity-among-breast-cancer-in-china-30647https://curecurrent.com/trials/vr-ultrasound-guided-breast-localization-30648https://curecurrent.com/trials/the-effect-of-complex-decongest-ve-therapy-on-ox-dat-ve-stress-and-ant-ox-dants-30649https://curecurrent.com/trials/care-initiative-real-world-emulation-of-the-paloma-2-trial-30650https://curecurrent.com/trials/east-asian-breast-cancer-genome-atlas-and-recurrence-risk-prediction-30651https://curecurrent.com/trials/endo-brain-effects-of-endocrine-adjuvant-therapy-with-aromatase-inhibitors-on-the-cognitive-function-of-breast-cancer-pa-30652https://curecurrent.com/trials/online-individual-intervention-program-to-make-sense-of-people-s-experiences-after-a-breast-cancer-diagnosis-30653https://curecurrent.com/trials/treatment-of-metastatic-breast-cancer-with-fulvestrant-plus-palbociclib-or-tamoxifen-plus-palbociclib-30654https://curecurrent.com/trials/reborn-lifestyle-adjustment-program-30655https://curecurrent.com/trials/exert-bcn-an-exercise-and-nutrition-regimen-to-designed-to-improve-body-composition-after-treatment-for-breast-cancer-30656https://curecurrent.com/trials/the-application-of-pectoral-nerve-ii-pecs-ii-block-in-breast-fibroadenoma-resection-surgery-30657https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-ipsilateral-supraclavicular-lymph-node-dissection-for-breast-cancer-patients-30658https://curecurrent.com/trials/the-strive-study-development-of-a-blood-test-for-early-detection-of-multiple-cancer-types-30659https://curecurrent.com/trials/comparison-of-tp-and-tac-regimens-in-neoadjuvant-treatment-of-tnbc-30660https://curecurrent.com/trials/a-study-to-characterize-the-outcomes-of-olaparib-maintenance-monotherapy-in-newly-diagnosed-brcawt-ovarian-cancer-30661https://curecurrent.com/trials/observation-of-exhaled-voc-biomarkers-characteristics-in-admitted-women-with-breast-ultrasound-bi-rads-4-grade-30662https://curecurrent.com/trials/an-exploratory-clinical-study-of-dalpiciclib-an-amp-39-d-letrozole-combined-with-anlotinib-neoadjuvant-therapy-in-stage-30663https://curecurrent.com/trials/palbociclib-in-real-world-practice-30664https://curecurrent.com/trials/zoledronate-vitamin-d-and-calcium-with-or-without-strontium-89-or-samarium-153-in-preventing-or-delaying-bone-problems-i-30665https://curecurrent.com/trials/a-comparison-of-nab-php-and-tcbhp-efficacy-in-neoadjuvant-therapy-for-her2-positive-early-breast-cancer-30666https://curecurrent.com/trials/study-of-the-p16-gene-as-a-predictor-of-myelosuppression-in-breast-cancer-patients-30667https://curecurrent.com/trials/adjuvant-tamoxifen-compared-with-anastrozole-in-treating-postmenopausal-women-with-ductal-carcinoma-in-situ-30668https://curecurrent.com/trials/grateful-strides-toward-physical-activity-and-well-being-for-black-breast-cancer-survivors-30669https://curecurrent.com/trials/selective-sentinella-lymph-node-biopsy-with-indocyanine-green-in-patients-with-breast-cancer-30670https://curecurrent.com/trials/efficacy-of-preparation-in-self-hypnosis-by-anchoring-versus-conversational-hypnosis-used-alone-or-combined-in-patients-30671https://curecurrent.com/trials/quilt-2-015-a-study-of-amg-479-with-exemestane-or-fulvestrant-in-postmenopausal-women-with-hormone-receptor-positive-loc-30672https://curecurrent.com/trials/asprosin-in-breast-cancer-30673https://curecurrent.com/trials/study-of-nms-03305293-in-pts-with-selected-advanced-metastatic-solid-tumors-30674https://curecurrent.com/trials/open-label-phase-1-study-to-evaluate-duration-of-severe-neutropenia-after-same-day-dosing-of-eflapegrastim-in-patients-w-30675https://curecurrent.com/trials/tas-116-plus-palbociclib-in-breast-and-rb-null-cancer-30676https://curecurrent.com/trials/partial-breast-re-irradiation-in-women-in-women-with-locally-recurrent-breast-cancer-previously-treated-with-conservativ-30677https://curecurrent.com/trials/a-phase-i-ii-study-of-xzp-3287-in-metastasis-solid-tumors-30678https://curecurrent.com/trials/this-study-investigates-the-impact-of-single-nucleotide-polymorphisms-in-genes-involved-in-the-pharmacokinetics-and-toxi-30679https://curecurrent.com/trials/vaccine-therapy-in-preventing-cancer-recurrence-in-patients-with-non-metastatic-node-positive-her2-negative-breast-cance-30680https://curecurrent.com/trials/studying-the-effect-of-freeze-dried-table-grape-powder-on-blood-estrogen-levels-in-postmenopausal-women-30681https://curecurrent.com/trials/assessing-the-impact-of-the-microbiome-on-breast-cancer-radiotherapy-toxicity-30682https://curecurrent.com/trials/multi-reader-multi-case-cross-over-retrospective-study-to-evaluate-effectiveness-of-lunit-insight-dbt-30683https://curecurrent.com/trials/study-to-assess-safety-and-efficacy-of-asidna-in-combination-with-olaparib-in-participants-with-recurrent-solid-tumors-30684https://curecurrent.com/trials/whole-breast-lymph-node-irradiation-prone-compared-to-supine-position-in-15-or-5-fractions-30685https://curecurrent.com/trials/a-study-of-accelerated-3-fraction-photon-proton-or-brachytherapy-for-early-invasive-and-noninvasive-breast-ca-30686https://curecurrent.com/trials/jk-1201i-in-triple-negative-breast-cancer-patients-with-brain-metastases-30687https://curecurrent.com/trials/exploratory-research-on-constructing-a-computational-biological-model-based-on-ngs-for-mrd-after-breast-cancer-surgery-30688https://curecurrent.com/trials/tolerability-and-efficacy-of-adjuvant-t-dm1-in-patients-with-her2-positive-breast-cancer-after-incomplete-pathological-r-30689https://curecurrent.com/trials/optimal-surgical-approach-for-early-stage-breast-cancer-in-chinese-patients-aged-40-years-a-cohort-study-30690https://curecurrent.com/trials/study-of-stereotactic-radiotherapy-for-breast-cancer-30691https://curecurrent.com/trials/seroma-and-hematoma-rates-maxigesic-iv-vs-ketorolac-in-breast-cancer-surgery-30692https://curecurrent.com/trials/high-definition-medicine-for-solid-tumors-oncology-30693https://curecurrent.com/trials/neoadjuvant-shr-a1811-plus-adebrelimab-in-hr-negative-low-her2-low-breast-cancer-patients-30694https://curecurrent.com/trials/internal-mammary-lymph-nodes-irradiation-in-high-risk-breast-cancer-after-neoadjuvant-chemotherapy-30695https://curecurrent.com/trials/a-single-arm-prospective-phase-clinical-study-of-utidelone-combined-with-capecitabine-in-the-treatment-of-active-brain-m-30696https://curecurrent.com/trials/alert-a-phase-ii-study-of-alternating-eribulin-and-hormonal-therapy-in-pre-treated-er-ve-breast-cancer-30697https://curecurrent.com/trials/palliative-and-oncology-care-model-in-breast-cancer-30698https://curecurrent.com/trials/evaluating-patient-reported-outcomes-in-radiation-therapy-the-pro-rt-study-30699https://curecurrent.com/trials/assessing-depression-in-a-geriatric-cancer-population-30700https://curecurrent.com/trials/rise-up-after-breast-cancer-30701https://curecurrent.com/trials/turkish-version-of-breast-edema-questionnare-validity-and-reliability-study-30702https://curecurrent.com/trials/the-association-between-cbt-i-dose-and-innate-immunity-in-insomnia-and-fatigue-in-prostate-cancer-patients-30703https://curecurrent.com/trials/breast-health-education-for-underserved-latino-women-30704https://curecurrent.com/trials/caloric-restriction-and-exercise-for-protection-from-anthracycline-toxic-effects-30705https://curecurrent.com/trials/mental-and-cognitive-health-and-physical-activity-in-the-perioperative-breast-cancer-setting-30706https://curecurrent.com/trials/breast-cancer-index-bci-registry-30707https://curecurrent.com/trials/single-port-endoscopic-breast-conserving-surgery-30708https://curecurrent.com/trials/safety-pharmacokinetics-and-anti-tumor-activity-of-rp12146-in-patients-with-solid-tumors-30709https://curecurrent.com/trials/apatinib-combined-with-albumin-bound-paclitaxel-for-treatment-of-advanced-triple-negative-breast-cancer-30710https://curecurrent.com/trials/exercise-for-ameliorating-chemotherapy-cardiotoxicity-30711https://curecurrent.com/trials/effect-of-alnd-with-vein-branches-reservation-on-postoperative-upper-limb-edema-and-dysfunction-in-breast-cancer-30712https://curecurrent.com/trials/parp-inhibition-for-triple-negative-breast-cancer-er-pr-her2-with-brca1-2-mutations-30713https://curecurrent.com/trials/novel-immunotherapy-strategies-for-advanced-triple-negative-breast-cancer-tnbc-patients-tonic-3-trial-30714https://curecurrent.com/trials/a-multicenter-prospective-observational-cohort-based-on-a-breast-cancer-medical-record-database-in-china-30715https://curecurrent.com/trials/vitamin-d-supplementation-in-breast-cancer-patients-30716https://curecurrent.com/trials/educational-program-on-self-management-for-women-with-post-mastectomy-lymphedema-30717https://curecurrent.com/trials/monitoring-response-to-nac-and-prediction-of-pcr-in-breast-cancer-patients-using-optical-imaging-30718https://curecurrent.com/trials/correlation-of-timing-of-pegfilgrastim-administration-and-pibp-30719https://curecurrent.com/trials/study-on-physical-activity-s-relationship-with-cancer-and-cognition-30720https://curecurrent.com/trials/study-comparing-the-pharmacokinetics-of-ftd-as-a-component-of-tas-102-with-ftd-alone-30721https://curecurrent.com/trials/study-comparing-the-bioavailability-of-tas-102-tablets-to-an-oral-solution-containing-equivalent-amounts-of-ftd-and-tpi-30722https://curecurrent.com/trials/high-intensity-exercise-after-treatment-30723https://curecurrent.com/trials/study-to-evaluate-the-cardiac-safety-of-tas-102-in-patients-with-advanced-solid-tumors-30724https://curecurrent.com/trials/neuro-sacituzumab-govitecan-breast-brain-metastasis-glioblastoma-ph-0-30725https://curecurrent.com/trials/asian-multicenter-prospective-study-of-ctdna-sequencing-30726https://curecurrent.com/trials/pf-06804103-dose-escalation-in-her2-positive-and-negative-negative-only-in-part-2-solid-tumors-30727https://curecurrent.com/trials/where-culture-meets-genetics-exploring-latinas-causal-attributions-of-breast-and-colon-cancer-and-models-of-disease-inhe-30728https://curecurrent.com/trials/tonation-breathing-technique-method-to-ease-aromatase-inhibitor-induced-joint-and-or-muscle-pain-30729https://curecurrent.com/trials/anlotinib-with-trastuzumab-deruxtecan-for-previously-treated-her2-low-advanced-breast-cancer-30730https://curecurrent.com/trials/mindfulness-based-stress-reduction-in-helping-participants-with-metastatic-breast-cancer-30731https://curecurrent.com/trials/use-of-artificial-intelligence-in-the-symptomatic-breast-clinic-setting-30732https://curecurrent.com/trials/lifestyle-behavioural-intervention-on-breast-cancer-survivors-for-the-treatment-of-overweight-obesity-30733https://curecurrent.com/trials/dose-escalation-and-expansion-study-of-gsk525762-in-combination-with-fulvestrant-in-participants-with-hormone-receptor-p-30734https://curecurrent.com/trials/a-study-to-prevent-rash-in-people-starting-alpelisib-for-the-treatment-of-breast-cancer-30735https://curecurrent.com/trials/inetetamab-combined-with-paclitaxel-with-without-pertuzumab-for-previously-treated-her2-positive-advanced-breast-cancer-30736https://curecurrent.com/trials/arx788-in-her2-positive-metastatic-breast-cancer-patients-who-were-previously-treated-with-t-dxd-30737https://curecurrent.com/trials/mind-programme-for-women-with-breast-cancer-30738https://curecurrent.com/trials/under-and-overdiagnosis-in-breastscreen-norway-30739https://curecurrent.com/trials/prevention-of-paclitaxel-induced-neuropathic-pain-in-patients-with-planned-paclitaxel-chemotherapy-prevtel-30740https://curecurrent.com/trials/survivorship-promotion-in-reducing-igf-1-trial-30741https://curecurrent.com/trials/deslorelin-combined-with-low-dose-add-back-estradiol-and-testosterone-in-preventing-breast-cancer-in-premenopausal-women-30742https://curecurrent.com/trials/the-digital-breast-tomosynthesis-trial-in-bergen-30743https://curecurrent.com/trials/the-tomosynthesis-trial-in-bergen-part-2-30744https://curecurrent.com/trials/motiva-flora-tissue-expander-pmcf-30745https://curecurrent.com/trials/retrospective-data-collection-on-the-use-of-motiva-flora-te-in-breast-reconstruction-30746https://curecurrent.com/trials/permanence-of-indocyanine-green-in-axillary-lymph-nodes-3-weeks-after-subdermal-injection-in-patients-with-breast-cancer-30747https://curecurrent.com/trials/prospective-analysis-of-envisio-spatial-intelligence-for-soft-tissue-localization-and-guided-surgical-excision-30748https://curecurrent.com/trials/evaluation-of-an-integrated-imaging-system-for-in-vivo-detection-of-fluorescently-labeled-lesions-30749https://curecurrent.com/trials/faith-in-action-a-church-based-navigation-model-to-increase-breast-cancer-screening-in-korean-women-30750https://curecurrent.com/trials/a-study-of-bria-ots-cellular-immunotherapy-in-metastatic-recurrent-breast-cancer-30751https://curecurrent.com/trials/wearable-enhanced-fitness-tracking-for-metastatic-breast-cancer-patients-using-endocrine-treatment-and-palbociclib-30752https://curecurrent.com/trials/a-study-of-bi-ligand-drug-conjugate-cbp-1019-in-patients-with-advanced-solid-tumors-30753https://curecurrent.com/trials/d4-choline-breast-pet-ct-30754https://curecurrent.com/trials/herpet-a-novel-pet-imaging-study-of-her2-in-breast-cancer-30755https://curecurrent.com/trials/group-therapy-for-primary-breast-cancer-30756https://curecurrent.com/trials/sitravatinib-in-metastatic-breast-cancer-30757https://curecurrent.com/trials/precision-performance-status-assessment-in-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-30758https://curecurrent.com/trials/cook-for-your-life-implementing-dietary-change-among-hispanic-breast-cancer-survivors-30759https://curecurrent.com/trials/study-of-disitamab-vedotin-with-toripalimab-verus-disitamab-vedotin-in-hormone-receptor-positive-her2-low-locally-advanc-30760https://curecurrent.com/trials/vaccine-based-immunotherapy-regimen-for-nsclc-and-tnbc-30761https://curecurrent.com/trials/real-world-treatment-patterns-and-effectiveness-of-palbociclib-and-ai-therapy-30762https://curecurrent.com/trials/cts2190-phase-i-ii-clinical-study-in-patients-30763https://curecurrent.com/trials/denosumab-and-mri-breast-imaging-30764https://curecurrent.com/trials/improving-cognition-after-cancer-30765https://curecurrent.com/trials/mrd-in-high-risk-ebc-30766https://curecurrent.com/trials/breast-cancer-lung-late-effects-30767https://curecurrent.com/trials/a-phase-1-study-of-talazoparib-parp-inhibitor-in-japanese-patients-with-advanced-solid-tumors-30768https://curecurrent.com/trials/pilot-study-of-pacha-program-to-enhance-adherence-to-adjuvant-endocrine-therapy-among-breast-cancer-survivors-30769https://curecurrent.com/trials/surveillance-imaging-modalities-for-breast-cancer-assessment-30770https://curecurrent.com/trials/a-first-in-human-study-of-can04-in-patients-with-solid-malignant-tumors-30771https://curecurrent.com/trials/de-escalating-axillary-surgery-in-breast-cancer-patients-in-nigeria-30772https://curecurrent.com/trials/the-effectiveness-of-e-health-intervention-in-improving-mental-health-outcomes-among-breast-cancer-patients-30773https://curecurrent.com/trials/effects-of-acupressure-and-aromatherapy-on-nausea-and-vomiting-severity-anxiety-and-comfort-level-30774https://curecurrent.com/trials/molecular-subtyping-of-triple-negative-breast-cancer-and-african-ancestry-related-immunogenicity-30775https://curecurrent.com/trials/diagnostic-performance-of-18f-fes-pet-ct-for-axillary-ln-metastasis-in-invasive-lobular-carcinoma-30776https://curecurrent.com/trials/long-term-use-of-ccb-and-breast-cancer-risk-30777https://curecurrent.com/trials/the-clearcoast-magnetic-resonance-outcome-pms-study-30778https://curecurrent.com/trials/vaccine-therapy-and-cyclophosphamide-in-treating-patients-with-stage-ii-iii-breast-or-stage-ii-iv-ovarian-primary-perito-30779https://curecurrent.com/trials/music-therapy-in-patients-with-breast-cancer-a-randomized-controlled-trial-30780https://curecurrent.com/trials/microscopy-imaging-of-whole-mount-stained-human-tissues-30781https://curecurrent.com/trials/combined-optical-and-infrared-imaging-for-early-prediction-of-erythema-during-breast-and-chestwall-radiotherapy-30782https://curecurrent.com/trials/exercise-to-prevent-anthracycline-based-cardio-toxicity-study-2-0-exact2-30783https://curecurrent.com/trials/vitamin-b12-for-aromatase-inhibitors-associated-musculoskeletal-symptoms-in-breast-cancer-30784https://curecurrent.com/trials/the-effect-of-music-on-pain-anxiety-and-satisfaction-during-mammography-30785https://curecurrent.com/trials/safety-assessment-of-concurrent-radiotherapy-and-novel-systemic-therapy-for-breast-cancer-30786https://curecurrent.com/trials/cost-of-cancer-risk-management-in-women-at-elevated-genetic-risk-for-ovarian-cancer-who-participated-on-gog-0199-30787https://curecurrent.com/trials/a-study-comparing-atezolizumab-anti-pd-l1-antibody-in-combination-with-adjuvant-anthracycline-taxane-based-chemotherapy-30788https://curecurrent.com/trials/programmed-death-ligand1-expression-in-her-2-positive-and-triple-negative-breast-cancer-30789https://curecurrent.com/trials/ufpti-2105-br05-improving-breast-radiotherapy-setup-and-delivery-using-mixed-reality-visualization-30790https://curecurrent.com/trials/combination-followed-by-maintenance-chemotherapy-versus-cdk4-6-inhibitor-combined-with-endocrine-therapy-for-hr-low-her2-30791https://curecurrent.com/trials/eribulin-mesylate-or-paclitaxel-as-first-or-second-line-therapy-in-treating-patients-with-recurrent-stage-iiic-iv-breast-30792https://curecurrent.com/trials/to-evaluate-the-effectiveness-and-safety-of-the-single-port-robotic-assisted-breast-surgery-in-breast-cancer-30793https://curecurrent.com/trials/primary-operation-in-synchronous-metastasized-invasive-breast-cancer-30794https://curecurrent.com/trials/a-study-of-treatment-patterns-and-outcomes-in-participants-with-human-epidermal-growth-factor-receptor-2-her2-positive-u-30795https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-of-apg-2575-as-a-single-agent-or-in-combination-for-breast-cancer-30796https://curecurrent.com/trials/precision-treatment-of-hr-her2-advanced-breast-cancer-based-on-snf-molecular-subtyping-30797https://curecurrent.com/trials/feasibility-of-fasting-exercise-in-pts-with-hr-mbc-30798https://curecurrent.com/trials/comparison-of-pre-op-and-post-op-pectoralis-nerve-block-30799https://curecurrent.com/trials/real-world-clinical-outcomes-and-toxicity-in-metastatic-breast-cancer-patients-treated-with-first-or-second-line-cdk-4-6-30800https://curecurrent.com/trials/micrornas-and-prognosis-in-breast-cancer-30801https://curecurrent.com/trials/a-study-to-investigate-the-effects-of-tibolone-livial-on-breast-tissue-in-postmenopausal-women-with-breast-cancer-study-30802https://curecurrent.com/trials/evaluating-the-effectiveness-of-an-early-exercise-program-after-breast-reconstruction-30803https://curecurrent.com/trials/evaluation-of-adm-sc-derm-recon-in-breast-reconstruction-30804https://curecurrent.com/trials/the-effects-of-laughter-yoga-and-mindfulness-based-stress-reduction-mbsr-practices-applied-to-women-with-breast-cancer-30805https://curecurrent.com/trials/pharmacogenomics-testing-in-the-optimal-use-of-supportive-care-medications-in-stage-iii-iv-cancer-30806https://curecurrent.com/trials/regional-anesthesia-in-breast-surgery-30807https://curecurrent.com/trials/pemigatinib-and-immune-checkpoint-inhibitor-treated-fgfr1-2-3-alteration-advanced-solid-tumor-30808https://curecurrent.com/trials/study-to-evaluate-tng348-alone-and-with-a-parp-inhibitor-in-patients-with-brca-1-2-mutant-or-hrd-solid-tumors-30809https://curecurrent.com/trials/evaluation-of-axillary-lymph-node-metastasis-status-of-breast-cancer-based-on-pathological-images-and-virtual-staining-30810https://curecurrent.com/trials/t-dm1-and-palbociclib-for-metastatic-her2-breast-cancer-30811https://curecurrent.com/trials/of-androgen-receptor-expression-in-breast-cancer-with-or-without-brca-mutation-30812https://curecurrent.com/trials/efficacy-and-safety-of-tenalisib-rp6530-in-patients-with-locally-advanced-or-metastatic-breast-cancer-30813https://curecurrent.com/trials/prediction-of-non-sentinel-lymph-node-metastatic-status-of-breast-cancer-based-on-pathology-mri-images-30814https://curecurrent.com/trials/danish-breast-cancer-group-internal-mammary-node-study-30815https://curecurrent.com/trials/t-dxd-versus-thp-for-medium-risk-her2-positive-early-breast-cancer-30816https://curecurrent.com/trials/implementing-breastchoice-into-practice-30817https://curecurrent.com/trials/current-status-of-treatment-for-chinese-patients-with-esr1-mutated-hr-her2-advanced-breast-cancer-30818https://curecurrent.com/trials/testosterone-tamoxifen-trial-30819https://curecurrent.com/trials/demonstration-of-a-novel-approach-using-surface-image-guidance-to-improve-delivery-of-breast-radiotherapy-30820https://curecurrent.com/trials/physical-and-health-outcomes-with-exercise-in-cancer-survivors-30821https://curecurrent.com/trials/safety-of-elacestrant-in-er-her2-and-esr1-mutations-mbc-30822https://curecurrent.com/trials/a-study-of-zn-c5-in-subjects-with-breast-cancer-30823https://curecurrent.com/trials/a-study-for-dynamic-prediction-model-of-breast-cancer-bone-metastases-30824https://curecurrent.com/trials/prehabilitation-and-recovery-from-surgery-for-breast-cancer-study-30825https://curecurrent.com/trials/quilt-3-067-nant-triple-negative-breast-cancer-tnbc-vaccine-molecularly-informed-integrated-immunotherapy-in-subjects-wi-30826https://curecurrent.com/trials/chidamide-and-pd-1-inhibitor-plus-anlotinib-for-her2-low-breast-cancer-that-has-spread-or-cannot-be-surgically-removed-30827https://curecurrent.com/trials/cea-targeting-chimeric-antigen-receptor-t-lymphocytes-car-t-in-the-treatment-of-cea-positive-advanced-solid-tumors-30828https://curecurrent.com/trials/phytocannabinoids-for-the-treatment-of-chronic-chemotherapy-induced-peripheral-neuropathy-in-breast-and-colon-cancer-sur-30829https://curecurrent.com/trials/optimizing-pulmonary-health-and-quality-of-life-in-breast-cancer-survivors-a-randomized-controlled-trial-combining-incen-30830https://curecurrent.com/trials/examination-of-the-effect-of-counselling-and-follow-up-after-breast-cancer-awareness-education-30831https://curecurrent.com/trials/deep-learning-with-mri-based-multimodal-data-fusion-enhanced-postoperative-risk-stratification-of-breast-cancer-30832https://curecurrent.com/trials/a-phase-iv-study-to-collect-data-on-the-efficacy-and-safety-of-ribociclib-in-older-women-with-breastcancer-30833https://curecurrent.com/trials/a-study-of-bpi-1178-in-patients-with-advanced-solid-tumor-and-hr-her2-breast-cancer-30834https://curecurrent.com/trials/efficacy-of-voriconazole-loaded-spanlastics-gel-versus-clotriamazole-cream-on-treating-vulvovaginal-candidasis-30835https://curecurrent.com/trials/health-belief-model-based-nursing-interventions-on-lymphedema-prevention-30836https://curecurrent.com/trials/smart-vr-mindfulness-for-breast-cancer-integrating-biofeedback-and-evaluating-chemotherapy-effectiveness-30837https://curecurrent.com/trials/multimedia-assisted-informed-consent-procedure-for-patients-undergoing-mastectomy-and-implant-based-reconstruction-30838https://curecurrent.com/trials/role-of-diffusion-weighted-image-in-the-diagnosis-and-follow-up-of-breast-cancer-30839https://curecurrent.com/trials/effect-of-education-on-breast-cancer-fear-and-health-beliefs-30840https://curecurrent.com/trials/cipn-prevention-trial-evaluating-the-efficacy-of-hand-cooling-and-hand-compression-30841https://curecurrent.com/trials/phytoestrogens-and-breast-cancer-effects-of-phytoestrogens-on-markers-of-disease-progression-and-gene-expression-30842https://curecurrent.com/trials/effect-of-intravenous-s-ketamine-on-opioid-consumption-30843https://curecurrent.com/trials/efficacy-and-resistant-mechanism-of-eribulin-and-bevacizumab-for-advanced-her2-negative-breast-cancer-30844https://curecurrent.com/trials/mri-based-approaches-for-multi-parametric-model-to-early-predict-pathological-complete-response-to-neoadjuvant-therapy-i-30845https://curecurrent.com/trials/exercise-effect-on-chemotherapy-induced-neuropathic-pain-30846https://curecurrent.com/trials/measuring-and-improving-the-safety-of-test-result-follow-up-30847https://curecurrent.com/trials/quilt-3-040-etbx-011-ad5-e1-e2b-cea-6d-vaccine-in-combination-with-alt-803-super-agonist-il-15-in-subjects-having-cea-ex-30848https://curecurrent.com/trials/single-fraction-preoperative-radiotherapy-for-early-stage-breast-cancer-30849https://curecurrent.com/trials/neoadjuvant-trastuzumab-deruxtecan-t-dxd-with-response-directed-definitive-therapy-in-early-stage-her2-positive-breast-c-30850https://curecurrent.com/trials/radioso-milan-i-radar-reflector-localisation-scout-for-carcinoma-mammae-the-milan-ieo-experience-i-30851https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetic-pk-study-of-dhes0815a-in-participants-with-human-epidermal-growth-factor-recepto-30852https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-subcutaneously-compared-intravenous-administration-in-the-treatment-of-her2-positive-30853https://curecurrent.com/trials/milaberon-in-advanced-solid-tumors-an-open-multicenter-clinical-study-30854https://curecurrent.com/trials/her-2-pulsed-dc-vaccine-to-prevent-recurrence-of-invasive-breast-cancer-post-neoadjuvant-chemotherapy-30855https://curecurrent.com/trials/longitudinal-study-of-behavioral-changes-economic-and-sociological-after-cancer-30856https://curecurrent.com/trials/neoadjuvant-treatment-of-locally-advanced-breast-cancer-patients-with-ribociclib-and-letrozole-30857https://curecurrent.com/trials/biofeedback-training-on-shoulder-muscles-strength-post-mastectomy-30858https://curecurrent.com/trials/gut-and-tumor-microbiome-in-patients-with-early-stage-ii-iii-locally-advanced-or-advanced-er-positive-and-her2-negative-30859https://curecurrent.com/trials/lm-108-in-combination-with-pd-1-based-treatment-for-patients-with-recurrent-or-metastatic-triple-negative-breast-cancer-30860https://curecurrent.com/trials/first-line-gemcitabine-plus-cisplatin-in-locally-advanced-iiic-stage-breast-cancer-patients-30861https://curecurrent.com/trials/gm1-prophylaxis-for-post-chemotherapy-cognitive-impairment-in-patients-with-early-operable-breast-cancer-30862https://curecurrent.com/trials/the-robot-lva-study-robot-assisted-microsurgical-lymphaticovenous-anastomosis-in-breast-cancer-related-lymphedema-30863https://curecurrent.com/trials/evaluation-of-the-safety-and-tolerability-of-niraparib-with-everolimus-in-advanced-gynecologic-malignancies-and-breast-30864https://curecurrent.com/trials/a-study-of-xs-02-capsules-in-patients-with-advanced-solid-tumors-30865https://curecurrent.com/trials/gm1-prophylaxis-for-wbrt-related-cognitive-dysfunction-30866https://curecurrent.com/trials/trilaciclib-a-cdk-4-6-inhibitor-in-patients-receiving-gemcitabine-and-carboplatin-for-metastatic-triple-negative-breast-30867https://curecurrent.com/trials/phase-iii-study-shr6390-placebo-combined-with-endocrine-therapy-for-the-adjuvant-treatment-of-hormone-receptor-positive-30868https://curecurrent.com/trials/clinical-utility-of-fes-f18-pet-ct-in-metastatic-breast-cancer-patients-30869https://curecurrent.com/trials/investigation-of-genetic-determinants-of-capecitabine-toxicity-30870https://curecurrent.com/trials/real-world-study-on-the-management-of-hematological-toxicities-associated-with-targeted-therapies-for-breast-cancer-30871https://curecurrent.com/trials/implication-of-ccr4-not-complex-subunit-7-expression-in-natural-killer-cell-resistance-in-metastatic-breast-cancer-30872https://curecurrent.com/trials/self-monitoring-activity-a-randomized-trial-of-game-oriented-applications-30873https://curecurrent.com/trials/a-dose-escalation-study-evaluating-the-safety-and-tolerability-of-gdc-0032-in-participants-with-locally-advanced-or-meta-30874https://curecurrent.com/trials/a-single-arm-clinical-study-of-dendritic-cell-vaccine-loaded-with-circular-rna-encoding-cryptic-peptide-for-patients-wit-30875https://curecurrent.com/trials/hypofractionated-image-guided-radiation-therapy-in-treating-patients-with-stage-iv-breast-cancer-30876https://curecurrent.com/trials/a-rct-of-psychosocial-interventions-facilitating-positive-psychological-adaptation-in-breast-cancer-30877https://curecurrent.com/trials/personalized-neoadjuvant-strategy-er-positive-and-her2-negative-breast-cancer-to-increase-bcs-rate-30878https://curecurrent.com/trials/a-study-of-avelumab-in-combination-with-other-cancer-immunotherapies-in-advanced-malignancies-javelin-medley-30879https://curecurrent.com/trials/simple-simulation-based-breast-cancer-awareness-training-30880https://curecurrent.com/trials/study-of-irinotecan-liposome-injection-in-patients-with-advanced-breast-cance-30881https://curecurrent.com/trials/comparing-efficacy-and-safety-between-pertuzumab-and-perjeta-in-neoadjuvant-treatment-of-her2-breast-cancer-30882https://curecurrent.com/trials/artificial-intelligence-assisted-breast-ultrasound-in-breast-cancer-screening-30883https://curecurrent.com/trials/cancer-patient-perspectives-during-covid-19-30884https://curecurrent.com/trials/ipatasertib-plus-non-taxane-chemotherapy-for-advanced-or-metastatic-triple-negative-breast-cancer-30885https://curecurrent.com/trials/laser-speckle-imaging-during-breast-reconstruction-30886https://curecurrent.com/trials/a-phase-ii-trial-testing-oral-administration-of-lucitanib-in-patients-with-fibroblast-growth-factor-receptor-fgfr-1-ampl-30887https://curecurrent.com/trials/clinical-application-of-ctdna-dynamic-monitoring-in-neoadjuvant-therapy-for-her2-positive-breast-cancer-patients-30888https://curecurrent.com/trials/phase-1-study-of-ucmym802-injection-in-mesothelin-positive-advanced-malignant-solid-tumors-30889https://curecurrent.com/trials/effect-of-kefir-on-symptom-management-and-quality-of-life-in-oncology-30890https://curecurrent.com/trials/typhoid-vaccine-in-testing-response-to-immune-stress-in-patients-with-stage-i-iiia-breast-cancer-30891https://curecurrent.com/trials/collaborative-community-care-for-metastatic-breast-cancer-patients-in-indonesia-communicated-30892https://curecurrent.com/trials/efficacy-of-angiography-with-indocyanine-green-in-the-identification-of-complications-after-breast-surgery-30893https://curecurrent.com/trials/southeast-netherlands-advanced-metastatic-breast-cancer-registry-30894https://curecurrent.com/trials/a-real-life-study-to-learn-about-the-use-and-effects-of-the-cdk4-6-inhibitors-in-canadian-patients-with-breast-cancer-30895https://curecurrent.com/trials/treatment-of-breast-fibroadenoma-with-high-intensity-focused-ultrasound-hifu-30896https://curecurrent.com/trials/u-s-guided-rhomboid-intercostal-block-combined-with-sub-serratus-plane-block-vs-type-2-pectoral-nerve-block-30897https://curecurrent.com/trials/comparison-of-conventional-with-sonography-assisted-breast-surgery-30898https://curecurrent.com/trials/effect-of-esketamine-on-postoperative-depression-gut-microbiota-bispectral-index-data-of-depression-patients-undergoing-30899https://curecurrent.com/trials/a-study-to-explore-safety-tolerability-pharmacokinetics-and-anti-tumor-activity-of-novel-therapeutics-in-patients-with-e-30900https://curecurrent.com/trials/correlation-between-serum-tk1-and-pathological-remission-of-breast-cancer-with-neoadjuvant-chemotherapy-30901https://curecurrent.com/trials/an-ai-model-predicts-the-efficacy-of-neoadjuvant-chemotherapy-for-breast-cancer-a-multicenter-bidirectional-cohort-study-30902https://curecurrent.com/trials/hr-her2-advanced-or-metastatic-breast-cancer-patients-treated-with-sacituzumab-govitecan-30903https://curecurrent.com/trials/neoadjuvant-therapy-with-weekly-utidelone-combined-with-cisplatin-for-patients-with-breast-cancer-neourania-30904https://curecurrent.com/trials/a-study-to-evaluate-safety-efficacy-pharmacokinetics-and-immunogenicity-of-test-pertuzumab-zrc-3277-cadila-healthcare-lt-30905https://curecurrent.com/trials/a-phase-ii-study-of-triple-negative-breast-cancer-brain-metastases-30906https://curecurrent.com/trials/a-study-of-gnc-035-a-tetra-specific-antibody-in-participants-with-locally-advanced-or-metastatic-solid-tumors-30907https://curecurrent.com/trials/ctdna-monitoring-in-early-breast-cancer-30908https://curecurrent.com/trials/development-of-the-wearable-arm-volume-measurement-device-and-mobile-application-30909https://curecurrent.com/trials/organoid-model-predictive-of-response-to-immunotherapies-30910https://curecurrent.com/trials/nurse-led-mobile-app-effect-on-symptom-management-for-breast-cancer-patients-after-surgery-30911https://curecurrent.com/trials/evaluating-positron-emission-mammography-imaging-of-suspicious-breast-abnormalities-30912https://curecurrent.com/trials/locoregional-recurrence-of-breast-cancer-30913https://curecurrent.com/trials/evaluation-of-an-mhealth-intervention-to-promote-participation-in-breast-cancer-screening-in-argentina-30914https://curecurrent.com/trials/the-unmet-needs-and-the-workplace-reintegration-of-breast-cancer-patients-the-new-breca-project-30915https://curecurrent.com/trials/clinical-study-of-18f-fapi-rgd-in-breast-tumors-30916https://curecurrent.com/trials/factors-influencing-cascade-testing-among-women-with-hereditary-gynecological-cancers-and-their-relatives-30917https://curecurrent.com/trials/cardiac-rehabilitation-for-patients-receiving-radiation-therapy-for-thoracic-cancers-30918https://curecurrent.com/trials/predicting-response-to-neoadjuvant-chemotherapy-in-locally-advanced-breast-cancer-30919https://curecurrent.com/trials/the-effect-of-manual-lymph-drainage-in-the-treatment-of-breast-edema-30920https://curecurrent.com/trials/exercise-intervention-in-women-diagnosed-with-triple-negative-breast-cancer-receiving-oncologic-treatment-30921https://curecurrent.com/trials/topical-menthol-for-the-treatment-of-chemotherapy-induced-peripheral-neuropathy-30922https://curecurrent.com/trials/single-fraction-high-gradient-partial-breast-irradiation-in-treating-patients-with-low-risk-stage-0-i-breast-cancer-30923https://curecurrent.com/trials/study-to-describe-the-real-world-treatment-patterns-and-associated-outcomes-in-patients-with-her2-positive-unresectable-30924https://curecurrent.com/trials/coping-together-after-breast-cancer-30925https://curecurrent.com/trials/application-of-rapid-on-site-evaluation-in-lymph-node-biopsy-of-breast-cancer-30926https://curecurrent.com/trials/phase-ii-short-term-adjuvant-therapy-and-biomarker-studies-with-targeted-agents-in-women-with-estrogen-receptor-negative-30927https://curecurrent.com/trials/airwave-compression-therapy-to-prevent-breast-cancer-related-lymphedema-30928https://curecurrent.com/trials/alpha-tea-and-trastuzumab-for-the-treatment-of-refractory-her2-metastatic-breast-cancer-30929https://curecurrent.com/trials/the-effect-of-breast-cancer-prevention-journey-program-30930https://curecurrent.com/trials/u-s-guided-transversus-thoracic-and-pectoral-nerve-block-versus-pectoral-nerve-block-in-mrm-30931https://curecurrent.com/trials/aromatherapy-in-the-treatment-of-early-breast-cancer-30932https://curecurrent.com/trials/detection-and-prevention-of-anthracycline-related-cardiac-toxicity-with-concurrent-simvastatin-30933https://curecurrent.com/trials/direct-information-to-at-risk-relatives-30934https://curecurrent.com/trials/correlation-study-of-serum-her-2-against-her-2-adc-drug-efficacy-in-her-2-low-expressing-breast-cancer-30935https://curecurrent.com/trials/study-of-imprime-pgg-and-pembrolizumab-in-advanced-melanoma-and-triple-negative-breast-cancer-30936https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-for-oligoprogressive-breast-cancer-30937https://curecurrent.com/trials/imaging-pilot-study-of-the-v-6-integrin-radiotracer-18f-a20fmdv2-in-patients-with-solid-cancer-types-30938https://curecurrent.com/trials/shared-decision-making-in-surveillance-for-distant-metastasis-in-breast-cancer-30939https://curecurrent.com/trials/dasatinib-combined-with-quercetin-to-reverse-chemo-resistance-in-triple-negative-breast-cancer-30940https://curecurrent.com/trials/short-term-preoperative-treatment-with-enzalutamide-alone-or-in-combination-with-exemestane-in-primary-breast-cancer-30941https://curecurrent.com/trials/the-impact-of-respiratory-training-of-dibh-radiotherapy-for-breast-cancer-30942https://curecurrent.com/trials/68ga-rm26-rgd-pet-ct-imaging-in-the-grpr-and-v-3-positive-tumor-patients-30943https://curecurrent.com/trials/a-study-of-shr-a1811-monotherapy-or-combined-with-pyrotinib-maleate-as-neoadjuvant-treatment-in-her2-positive-breast-can-30944https://curecurrent.com/trials/a-study-of-xmab-23104-in-subjects-with-selected-advanced-solid-tumors-duet-3-30945https://curecurrent.com/trials/biomarkers-of-neuropathic-pain-in-women-treated-for-breast-cancer-30946https://curecurrent.com/trials/breast-cancer-and-its-relationship-with-the-microbiota-30947https://curecurrent.com/trials/translating-research-into-practice-patient-navigation-for-breast-cancer-30948https://curecurrent.com/trials/oncotype-dx-in-brca-mutated-breast-cancer-patients-our-experience-a-retrospective-observational-monocentric-study-30949https://curecurrent.com/trials/efficacy-and-accuracy-of-combined-localization-versus-single-localization-in-non-palpable-breast-cancer-30950https://curecurrent.com/trials/real-world-clinical-benefit-evaluation-in-breast-cancer-patients-with-pharmaceutical-interventions-for-cancer-related-fa-30951https://curecurrent.com/trials/efficacy-and-accuracy-of-combined-localization-versus-single-localization-in-non-palpable-breast-cancer-after-neoadjuvan-30952https://curecurrent.com/trials/pyrotinib-and-subcutaneous-preparation-of-trastuzumab-combined-with-capecitabine-neoadjuvant-therapy-for-her2-study-of-b-30953https://curecurrent.com/trials/letrozole-in-preventing-breast-cancer-in-postmenopausal-women-with-a-brca1-or-brca2-mutation-30954https://curecurrent.com/trials/t-dm1-combined-with-cdk4-6-inhibitor-ribociclib-30955https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-investigation-of-stimotimagene-copolymerplasmid-30956https://curecurrent.com/trials/potential-benefits-of-radiotherapy-in-prone-position-for-breast-cancer-patients-a-planning-study-30957https://curecurrent.com/trials/a-study-of-prt3645-in-participants-with-select-advanced-or-metastatic-solid-tumors-30958https://curecurrent.com/trials/use-of-fractional-co2-laser-versus-erbium-yag-laser-for-the-treatment-of-gsm-in-patients-using-aromatase-inhibitors-30959https://curecurrent.com/trials/rws-of-paclitaxel-liposome-combined-with-anti-her-2-monoclonal-antibody-30960https://curecurrent.com/trials/the-role-of-circadian-rhythms-in-cancer-related-symptoms-30961https://curecurrent.com/trials/usage-of-artificial-intelligence-integrated-usg-in-application-of-pectoral-block-in-mastectomies-30962https://curecurrent.com/trials/comparing-efficacy-and-safety-of-aryogen-pharmed-biosimilar-trastuzumab-aryotrust-versus-herceptin-in-breast-cancer-30963https://curecurrent.com/trials/evaluation-of-the-potential-impact-of-an-artificial-intelligence-solution-in-second-reading-of-organized-screening-30964https://curecurrent.com/trials/uz-ku-leuven-program-for-post-mortem-tissue-donation-to-enhance-research-30965https://curecurrent.com/trials/evaluation-of-the-interest-of-a-postural-and-functional-analysis-for-the-follow-up-of-the-adapted-motor-activity-of-pati-30966https://curecurrent.com/trials/an-observational-pilot-study-to-test-a-smartwatch-based-ema-method-during-exercise-with-breast-cancer-survivors-30967https://curecurrent.com/trials/intervention-study-based-on-real-world-data-to-improve-quality-of-life-after-breast-cancer-treatment-the-rebecca-2-study-30968https://curecurrent.com/trials/effects-of-a-physical-exercise-intervention-during-neoadjuvant-chemotherapy-in-women-with-breast-cancer-30969https://curecurrent.com/trials/an0025-and-pembrolizumab-combination-in-advanced-solid-tumors-30970https://curecurrent.com/trials/effect-of-huaier-granule-on-adjuvant-treatment-for-high-risk-early-stage-triple-negative-breast-cancer-30971https://curecurrent.com/trials/patientcareanywhere-internet-based-software-in-improving-communication-and-education-in-patients-with-cancer-and-their-h-30972https://curecurrent.com/trials/evaluation-of-bis-for-quantification-of-lymphedema-30973https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-efficacy-and-safety-of-subcutaneous-administration-of-the-fixed-dose-combinatio-30974https://curecurrent.com/trials/characterization-of-biophysical-and-mechanical-parameters-on-skin-of-breast-cancer-patients-30975https://curecurrent.com/trials/pf-06952229-treatment-in-adult-patients-with-advanced-solid-tumors-30976https://curecurrent.com/trials/efficacy-of-pyrotinib-plus-capecitabine-in-her2-positive-mbc-with-active-brain-metastases-that-have-failed-adcs-30977https://curecurrent.com/trials/3d-structural-imaging-of-human-breast-tissues-30978https://curecurrent.com/trials/intra-surgery-high-resolution-specimen-pet-ct-imager-for-margin-assessment-in-early-stage-breast-cancer-30979https://curecurrent.com/trials/adjuvant-paclitaxel-and-trastuzumab-for-node-negative-her2-positive-breast-cancer-30980https://curecurrent.com/trials/clinical-effectiveness-of-cem-in-diagnosis-of-additional-findings-at-preoperative-breast-magnetic-resonance-imaging-30981https://curecurrent.com/trials/trans-artery-intra-tumor-infusion-of-checkpoint-inhibitors-plus-chemodrug-for-immunotherapy-of-advanced-solid-tumors-30982https://curecurrent.com/trials/preoperative-immunotherapy-combined-with-stereotactic-radiation-therapy-boost-in-the-treatment-of-her2-negative-breast-c-30983https://curecurrent.com/trials/engineered-tils-car-tils-to-treat-advanced-solid-tumors-30984https://curecurrent.com/trials/pharmacodynamic-biomarkers-of-standard-anti-microtubule-drugs-as-assessed-by-early-tumor-biopsy-30985https://curecurrent.com/trials/egfr-b7h3-car-t-on-lung-cancer-and-triple-negative-breast-cancer-30986https://curecurrent.com/trials/triplex-checkpoint-inhibitors-therapy-for-advanced-solid-tumors-30987https://curecurrent.com/trials/endoscopic-extirpation-of-benign-breast-tumors-using-a-lateral-chest-wall-incision-30988https://curecurrent.com/trials/comparison-of-frailty-screening-performance-and-predictive-validity-of-adverse-health-outcomes-in-breast-cancer-patients-30989https://curecurrent.com/trials/to-evaluate-the-efficacy-of-adebrelimab-combined-with-chemotherapy-after-hifu-induction-neoadjuvant-therapy-hr-her2-brea-30990https://curecurrent.com/trials/a-health-education-intervention-tailored-for-malay-muslim-women-30991https://curecurrent.com/trials/contrast-enhanced-spectral-mammography-cesm-30992https://curecurrent.com/trials/64-cu-dota-alendronate-pet-imaging-in-localizing-and-characterizing-breast-calcifications-in-participants-before-undergo-30993https://curecurrent.com/trials/a-real-world-study-of-pyrrolitinib-maleate-tablets-for-her-2-positive-early-or-locally-advanced-breast-cancer-after-adju-30994https://curecurrent.com/trials/effect-of-psycho-educational-program-and-relaxation-training-on-resilience-among-women-with-breast-cancer-30995https://curecurrent.com/trials/study-to-compare-the-safety-of-immediate-one-stage-ibbr-with-expander-implant-two-stage-ibbr-augmented-with-tiloop-bra-c-30996https://curecurrent.com/trials/a-study-to-assess-the-mass-balance-recovery-metabolite-profile-and-metabolite-identification-of-14c-azd9833-30997https://curecurrent.com/trials/study-of-fluorodeoxyglucose-fluglucoscan-in-patients-with-breast-cancer-correlation-with-histologic-findings-of-sentinel-30998https://curecurrent.com/trials/apollo-device-for-metastatic-breast-cancer-mbc-30999https://curecurrent.com/trials/identification-of-benign-and-malignant-breast-nodules-using-ultrasound-modulated-optical-tomography-a-multicenter-study-31000